hg_77163.1

Basic information about the TSS

---

TSS ID: hg_77163.1 Species: human Chr: chr7		Start: 6590264 End: 6590316 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: KJ903139 AK056149 Distance: 0 GeneID: 79034 HGNC/MGI_ID: HGNC:21702 UniProt_ID:

Gene_name: chromosome 7 open reading frame 26 Gene_symbol: C7orf26 Gene_synonyms: MGC2718 Gene_source: HGNC:21702

TATA-Box annotation

---

Distance to TSS:	269
Nearest PromoterID:	NM_001303039
Entrez ID:	79034
Nearest Unigene:	Hs.487511
Nearest Refseq:	NM_024067
Nearest Ensembl:	ENSG00000146576
Gene Name:	chromosome 7 open reading frame 26
Gene Alias:	-
Gene Description:	chromosome 7 open reading frame 26
Gene Type:	protein-coding
CpG%:	0.14
GC%:	0.716418
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@C7orf26 p2@C7orf26 p3@C7orf26 p4@C7orf26 p5@C7orf26
Sample		p1@C7orf26	p2@C7orf26	p3@C7orf26	p4@C7orf26	p5@C7orf26
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	21.82	1.75	6.04	1.56	0.78
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	24.89	0.61	5.46	2.02	0.61
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	22.18	1.54	3.67	1.93	0.58
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	18.71	2.91	4.78	2.08	1.04
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	20.70	3.37	4.72	0.22	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	19.57	2.33	4.26	1.74	0.97
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	22.44	2.61	6.97	2.83	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	22.77	3.63	4.84	1.94	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	23.51	4.27	6.41	1.50	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	19.13	5.80	11.59	1.74	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	23.85	5.66	12.94	4.45	0.81
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	21.55	6.91	14.64	2.85	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	5.00	0.64	1.29	1.61	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	4.21	1.20	0.15	1.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	5.49	0.88	1.54	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	6.54	1.51	1.01	2.01	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	2.84	1.31	1.53	0.87	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	4.22	1.69	1.27	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	3.73	0.53	0.53	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	4.21	0.75	1.35	1.65	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	4.81	0.80	1.74	1.34	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	2.93	0.86	1.55	1.21	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	5.04	1.03	1.29	0.90	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	4.85	0.73	2.43	0.73	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	5.93	0.77	0.77	2.06	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	5.70	0.63	0.95	0.95	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	7.14	1.10	0.00	1.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	4.72	1.18	1.65	1.65	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	4.85	0.81	2.10	0.97	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	4.34	1.63	1.27	1.27	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	5.02	0.42	1.05	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	4.69	0.98	1.17	0.78	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	5.28	0.21	1.27	1.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	6.76	0.82	0.33	0.82	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	5.61	0.75	0.56	0.93	0.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	5.17	0.96	1.15	1.72	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	6.34	1.02	1.23	1.23	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	5.24	0.40	1.81	1.21	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	3.51	0.54	0.54	2.43	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	4.56	0.96	0.48	0.24	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	5.65	0.71	1.18	1.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	4.83	0.59	1.32	0.59	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	4.01	0.21	1.90	1.27	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	5.59	0.52	2.10	1.92	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	4.02	0.80	1.20	1.61	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	4.19	0.70	0.93	1.63	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	5.28	0.48	2.64	1.92	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	5.36	0.89	1.19	1.79	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	5.98	0.24	2.15	0.48	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	5.66	0.81	1.21	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	6.56	0.41	1.23	0.61	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	6.00	0.44	2.67	2.00	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	5.68	0.35	1.06	1.42	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	9.94	0.66	1.66	1.99	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	3.36	0.84	0.84	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	2.30	1.38	0.46	0.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	5.83	1.30	3.24	0.97	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	5.78	1.28	2.25	1.61	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	5.66	0.63	0.31	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	6.35	1.41	0.00	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	3.36	0.00	1.12	1.12	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	4.78	0.80	0.80	0.80	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	5.78	0.34	0.68	0.34	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	4.87	0.32	1.30	1.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	6.74	0.35	2.13	0.71	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	4.39	0.98	0.00	1.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	4.96	0.50	0.50	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	7.51	0.47	0.47	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	6.95	0.33	0.33	0.99	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	8.04	1.24	0.31	1.86	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	5.81	1.22	0.92	0.92	0.00
Adipocyte - breast, donor1	11376-118A8	5.39	1.90	2.69	1.43	0.16
Adipocyte - breast, donor2	11327-117E4	6.42	0.96	1.60	0.64	0.64
Adipocyte - omental, donor1	11473-119C6	3.05	2.16	1.15	1.65	0.13
Adipocyte - omental, donor2	11474-119C7	4.48	2.24	0.00	2.24	0.00
Adipocyte - omental, donor3	11475-119C8	5.36	1.34	1.67	1.67	1.34
Adipocyte - perirenal, donor1	11476-119C9	5.10	4.47	1.91	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	7.70	0.00	0.00	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	4.52	2.26	1.35	1.81	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	7.30	2.78	1.74	2.78	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	9.00	2.35	0.59	2.54	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	6.43	1.54	1.80	0.26	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	8.08	1.12	1.67	1.67	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	7.05	2.94	3.53	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	9.81	1.13	1.53	1.53	0.64
Adipocyte differentiation, day08, donor2	13023-139D8	4.84	1.61	1.29	0.65	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	8.53	2.13	0.00	0.00	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	6.68	2.23	1.11	1.11	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	7.90	2.08	0.83	1.66	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	6.28	3.01	0.50	0.75	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	5.89	0.65	1.96	0.98	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	5.18	0.00	1.52	1.52	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	8.62	0.66	1.77	0.44	0.88
Alveolar Epithelial Cells, donor2	11590-120G6	14.34	1.43	2.51	1.79	0.72
Alveolar Epithelial Cells, donor3	11671-122G6	1.20	2.40	1.20	1.20	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	8.10	2.16	1.08	1.62	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	5.02	3.35	1.67	3.35	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	7.81	1.85	1.64	1.03	0.62
Anulus Pulposus Cell, donor1	11248-116E6	5.72	2.17	0.80	1.14	0.69
Anulus Pulposus Cell, donor2	11463-119B5	3.92	0.98	0.73	0.49	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	6.29	2.25	1.35	0.00	0.90
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	7.38	0.43	1.74	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	2.14	6.42	2.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	4.48	1.20	0.00	0.60	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	7.59	2.53	3.79	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	7.26	1.32	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	3.90	0.32	0.65	0.65	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	4.37	0.97	0.97	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	5.34	1.78	2.38	1.19	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	5.27	1.13	0.75	0.75	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	8.71	2.18	0.73	0.73	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	8.78	2.51	2.51	0.00	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	6.42	1.32	0.66	1.48	0.49
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	10.92	0.00	2.73	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	5.13	1.51	0.30	0.15	0.45
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	1.07	0.00	0.54	0.54	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	4.53	1.32	0.76	0.76	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	5.35	2.67	0.27	1.07	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	4.88	0.00	0.98	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	4.48	1.99	0.50	0.50	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	6.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	7.08	3.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	4.80	0.86	1.37	0.51	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	8.39	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	6.31	2.43	0.49	0.49	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	5.31	2.66	1.52	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	8.48	2.42	2.42	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	7.41	1.71	0.57	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	5.99	1.28	0.86	0.43	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	4.39	2.58	1.55	0.52	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	4.22	1.88	0.94	0.47	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	5.47	1.61	2.57	1.29	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	2.85	0.71	0.00	1.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	2.92	1.75	0.00	0.00	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	6.32	1.20	1.20	0.00	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	5.94	1.19	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	5.59	1.53	0.00	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	4.58	1.02	1.02	0.76	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	6.35	1.27	0.64	0.00	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	5.18	1.29	1.73	0.43	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	4.23	1.06	0.64	0.42	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	4.64	0.87	0.87	0.58	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	6.61	1.89	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	4.07	1.36	1.19	0.51	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	9.27	0.00	4.63	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	2.11	0.00	0.00	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	4.72	0.86	0.86	0.64	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	6.62	2.41	1.20	0.00	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	5.83	3.64	0.00	0.73	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	5.29	1.38	0.23	0.46	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	2.55	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	5.34	1.53	2.80	1.02	0.76
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	4.34	1.65	1.24	0.21	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	4.28	2.45	0.61	0.61	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	6.21	2.87	1.43	0.00	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	3.99	1.33	0.67	0.67	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	4.58	1.53	1.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	2.22	1.66	0.55	1.11	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	4.77	2.12	1.06	0.53	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	4.36	2.54	0.73	0.00	0.36
Astrocyte - cerebellum, donor1	11500-119F6	10.32	2.33	3.32	2.70	0.74
Astrocyte - cerebellum, donor2	11580-120F5	12.15	2.23	1.88	2.40	0.86
Astrocyte - cerebellum, donor3	11661-122F5	11.33	0.63	2.31	1.47	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	7.67	1.05	0.35	1.05	0.70
Astrocyte - cerebral cortex, donor2	11316-117D2	16.02	1.94	2.91	1.46	0.81
Astrocyte - cerebral cortex, donor3	11392-118C6	13.87	1.19	1.79	1.49	0.45
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	18.92	2.98	1.15	1.26	0.80
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	18.17	2.38	2.26	1.13	0.50
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	16.96	2.73	2.16	1.25	0.23
Basophils, donor1	12241-129G9	15.69	1.83	1.05	1.05	0.52
Basophils, donor2	12242-129H1	20.93	6.13	3.25	1.80	0.72
Basophils, donor3	12243-129H2	22.93	1.03	2.06	1.32	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	3.88	2.16	2.16	1.08	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	10.06	2.29	2.29	2.29	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	0.00	7.17	0.00	0.00	7.17
Bronchial Epithelial Cell, donor4	11453-119A4	10.67	1.26	3.14	0.63	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	7.69	1.87	2.70	0.62	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	5.76	0.46	1.61	0.92	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	7.56	1.08	1.26	1.08	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	19.99	2.16	4.12	2.89	0.93
Burkitt's lymphoma cell line:RAJI	10476-106I8	15.84	3.96	1.86	0.93	1.40
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	25.26	6.40	0.96	1.92	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	0.00	0.00	10.34	0.00
CD14+ Monocytes, donor1	11224-116B9	16.34	0.56	0.56	1.13	0.00
CD14+ Monocytes, donor2	11305-117B9	24.13	0.56	1.48	0.93	0.19
CD14+ Monocytes, donor3	11381-118B4	26.34	0.88	3.07	1.54	0.44
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	11.60	1.70	1.98	1.98	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	10.61	1.14	1.14	1.90	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	9.53	0.66	1.31	0.99	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	13.30	1.01	1.59	1.01	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	10.26	1.21	0.30	0.91	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	9.48	0.95	1.90	1.42	0.71
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	9.71	0.00	0.17	0.67	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	5.80	0.55	0.83	0.55	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	7.93	0.99	0.50	0.50	0.50
CD14+ monocytes - treated with BCG, donor1	11860-125A6	5.48	0.20	0.78	0.20	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	4.27	0.18	0.71	0.00	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	7.83	0.44	0.00	0.22	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	7.96	0.47	0.00	0.47	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	5.28	0.00	0.53	0.53	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	11.09	0.00	1.11	0.00	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	9.07	0.59	1.64	0.59	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	5.19	0.40	1.00	0.60	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	7.08	0.62	0.83	0.62	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	5.95	0.00	0.69	0.69	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	4.75	0.45	0.90	0.45	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	7.42	0.00	0.44	0.44	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	4.57	1.34	1.88	0.81	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	5.41	0.17	0.17	0.87	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	10.10	1.26	0.84	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	4.04	0.18	0.37	0.37	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	2.47	0.00	0.35	0.35	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	6.14	0.00	0.44	0.44	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	4.01	0.17	0.00	0.00	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	3.35	0.37	0.74	0.37	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	7.33	0.22	0.22	1.29	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	2.87	0.00	0.41	0.82	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	2.09	0.00	0.00	0.23	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	5.10	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	14.82	2.18	1.31	0.65	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	24.25	0.69	2.31	2.54	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	16.68	0.65	2.17	0.87	1.08
CD14+CD16- Monocytes, donor1	11788-124B6	23.98	1.25	1.71	1.56	0.47
CD14+CD16- Monocytes, donor2	11799-124C8	24.80	1.57	1.22	1.75	0.70
CD14+CD16- Monocytes, donor3	11910-125G2	21.18	1.34	1.34	1.78	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	17.61	1.53	2.04	1.28	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	24.15	1.76	1.54	2.42	0.88
CD14-CD16+ Monocytes, donor3	11911-125G3	19.58	1.05	1.05	2.11	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	10.16	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	23.73	2.03	0.68	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	29.00	4.14	2.07	3.11	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	18.66	2.13	0.53	3.20	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	31.63	2.14	1.07	1.61	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	18.95	2.11	0.70	0.00	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	25.10	0.78	0.00	3.14	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	17.14	1.32	1.32	1.32	1.32
CD19+ B Cells, donor1	11544-120B5	37.81	0.00	0.82	0.82	0.00
CD19+ B Cells, donor2	11624-122B4	32.64	1.45	0.73	2.90	0.73
CD19+ B Cells, donor3	11705-123B4	38.87	1.01	0.50	3.03	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	7.68	0.81	0.40	0.81	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	6.39	0.40	1.60	0.80	0.00
CD34+ Progenitors, donor1	11545-120B6	22.09	1.00	2.01	1.00	0.00
CD34+ Progenitors, donor2	11625-122B5	16.85	4.49	0.00	0.00	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	19.16	1.88	3.76	1.50	1.50
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	15.56	4.06	1.58	1.13	1.13
CD4+ T Cells, donor1	11225-116C1	37.49	1.79	2.14	3.21	1.07
CD4+ T Cells, donor2	11306-117C1	56.34	4.90	1.22	3.06	0.61
CD4+ T Cells, donor3	11382-118B5	53.07	3.05	0.61	3.35	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	20.93	1.28	1.28	1.79	1.28
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	28.07	3.82	2.25	2.92	0.90
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	31.33	3.45	2.01	1.15	1.15
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	38.88	2.37	1.42	1.42	0.95
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	40.03	0.70	0.70	0.70	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	62.63	9.89	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	18.64	4.77	1.16	1.30	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	23.72	3.73	0.85	0.85	1.02
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	19.83	4.35	0.97	1.77	1.29
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	33.17	2.69	1.79	0.90	0.90
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	33.54	2.80	1.05	1.75	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	27.72	6.60	1.32	2.64	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	24.03	2.11	3.79	2.11	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	25.76	2.49	2.29	2.08	0.83
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	20.72	3.34	1.34	1.67	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	45.14	1.90	1.63	4.08	2.99
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	45.02	6.43	2.14	1.07	2.68
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	34.07	3.59	3.59	1.79	3.59
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	19.10	1.67	2.60	2.41	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	25.99	1.95	1.95	3.68	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	31.52	1.26	2.31	3.78	1.68
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	35.90	1.01	1.01	2.02	1.01
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	29.89	5.20	0.43	2.17	1.73
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	36.17	2.61	0.87	3.05	1.74
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	32.66	3.46	0.99	1.98	1.48
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	28.62	1.85	0.92	2.77	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	39.08	5.58	0.00	4.19	2.79
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	28.52	3.60	1.11	1.94	1.66
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	24.29	3.44	2.45	1.23	0.49
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	23.10	4.62	0.00	1.54	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	25.43	3.58	1.79	1.07	1.07
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	38.78	2.77	2.77	2.77	0.00
CD8+ T Cells, donor1	11226-116C2	53.04	2.29	2.29	2.29	0.98
CD8+ T Cells, donor2	11307-117C2	53.31	1.88	1.50	1.88	0.75
CD8+ T Cells, donor3	11383-118B6	66.40	3.79	2.02	2.52	1.26
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	12.85	5.51	0.46	0.69	0.92
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	13.18	6.47	0.48	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	12.04	5.47	1.09	1.09	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	15.01	5.70	0.90	0.00	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	12.00	6.48	0.96	0.24	1.20
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	11.60	6.14	0.23	0.68	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	14.99	3.91	0.65	0.43	0.87
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	11.58	4.74	0.79	0.26	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	12.19	6.33	1.41	0.23	0.47
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	9.66	3.32	0.60	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	15.98	4.36	2.32	0.58	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	10.92	4.26	1.33	0.27	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	11.82	3.50	0.88	0.88	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	11.84	2.28	1.37	0.91	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	9.70	0.75	1.49	1.49	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	11.52	6.12	0.72	1.44	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	15.25	6.33	0.29	1.44	0.58
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	11.31	6.60	0.24	0.71	0.71
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	11.41	4.75	0.63	1.27	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	12.61	5.54	0.62	1.54	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	10.58	4.49	0.96	0.32	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	7.65	2.29	0.76	0.00	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	14.19	4.34	0.00	0.79	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	11.35	3.78	0.00	0.76	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	12.04	3.21	0.00	2.41	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	13.99	3.50	2.10	0.70	1.40
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	13.02	3.01	0.00	1.00	0.00
Cardiac Myocyte, donor1	11525-119I4	3.66	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	13.34	1.48	0.49	1.98	0.00
Cardiac Myocyte, donor3	11686-122I3	5.89	0.63	0.84	2.10	0.00
Chondrocyte - de diff, donor1	11261-116G1	5.55	2.08	1.73	1.39	0.00
Chondrocyte - de diff, donor2	11338-117F6	8.17	2.13	1.78	0.71	0.00
Chondrocyte - de diff, donor3	11410-118E6	8.42	2.73	2.50	1.48	0.23
Chondrocyte - re diff, donor2	11339-117F7	3.58	1.79	1.79	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	16.18	2.02	0.81	2.43	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	9.87	2.75	1.95	1.61	0.46
Ciliary Epithelial Cells, donor2	11323-117D9	11.54	1.07	1.28	0.86	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	11.68	2.39	1.24	2.48	0.97
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	20.63	2.38	3.39	1.74	0.46
Corneal Epithelial Cells, donor1	11526-119I5	3.95	3.07	1.10	1.32	0.22
Corneal Epithelial Cells, donor2	11606-120I4	2.28	1.14	0.00	2.28	1.14
Corneal Epithelial Cells, donor3	11687-122I4	10.74	1.79	0.77	1.02	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	9.58	0.33	1.32	0.33	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	7.25	0.63	1.58	0.63	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	10.35	3.45	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	9.07	0.86	0.65	0.76	0.22
Dendritic Cells - plasmacytoid, donor1	11228-116C4	26.99	0.34	1.71	1.02	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	36.56	0.65	0.65	3.92	1.96
Dendritic Cells - plasmacytoid, donor3	11385-118B8	24.20	1.45	1.94	2.42	0.97
Endothelial Cells - Aortic, donor0	11207-116A1	5.34	0.67	1.33	1.17	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	8.21	0.59	0.59	0.59	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	14.71	0.85	1.41	1.41	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	9.44	1.18	0.39	0.39	0.79
Endothelial Cells - Artery, donor1	11264-116G4	9.60	2.91	1.45	1.16	0.00
Endothelial Cells - Artery, donor2	11341-117F9	14.12	1.18	2.59	1.65	0.00
Endothelial Cells - Artery, donor3	11413-118E9	14.38	2.63	1.93	1.23	0.53
Endothelial Cells - Lymphatic, donor1	11236-116D3	7.31	2.22	2.44	0.22	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	5.48	2.43	0.91	0.61	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	5.36	1.97	0.85	1.13	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	10.10	2.38	0.89	0.89	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	7.81	2.08	1.04	1.04	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	9.36	1.42	1.13	1.42	0.57
Endothelial Cells - Thoracic, donor1	11266-116G6	9.20	0.80	2.00	0.40	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	8.39	0.52	0.52	0.52	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	16.52	1.49	2.48	2.48	0.25
Endothelial Cells - Umbilical vein, donor2	11324-117E1	10.43	0.87	0.22	1.30	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	15.88	0.49	0.61	1.47	0.24
Endothelial Cells - Vein, donor1	11267-116G7	15.93	2.28	3.41	1.14	0.00
Endothelial Cells - Vein, donor2	11344-117G3	8.38	0.70	1.40	2.10	0.00
Endothelial Cells - Vein, donor3	11416-118F3	14.92	1.41	2.36	1.41	0.47
Eosinophils, donor1	12244-129H3	15.25	15.25	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	24.75	0.00	1.65	1.65	4.95
Eosinophils, donor3	12246-129H5	17.83	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	3.42	1.22	0.73	1.47	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	6.24	4.16	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	3.69	2.87	1.64	0.82	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	2.96	0.77	0.44	0.66	0.44
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	6.50	0.98	1.63	1.52	0.22
Fibroblast - Aortic Adventitial, donor1	11245-116E3	7.03	1.58	1.82	1.46	0.24
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	5.32	2.05	1.91	0.82	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	4.64	1.27	1.69	0.95	0.21
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	5.27	2.90	0.79	1.84	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	4.98	1.00	0.66	0.66	0.00
Fibroblast - Cardiac, donor1	11268-116G8	5.90	0.45	1.81	0.00	0.91
Fibroblast - Cardiac, donor2	11345-117G4	10.61	2.27	0.76	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	8.04	1.42	1.73	1.42	0.79
Fibroblast - Cardiac, donor4	11452-119A3	6.97	1.21	2.12	1.21	0.61
Fibroblast - Cardiac, donor5	11456-119A7	6.85	2.28	1.52	0.76	0.38
Fibroblast - Cardiac, donor6	11460-119B2	7.73	1.67	0.91	1.21	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	3.08	1.74	2.28	1.21	0.40
Fibroblast - Choroid Plexus, donor2	11572-120E6	4.75	1.29	0.86	0.43	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	8.79	0.00	2.93	1.46	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	14.99	2.77	3.23	3.00	0.46
Fibroblast - Conjunctival, donor3	11692-122I9	8.65	3.39	2.04	1.02	0.34
Fibroblast - Dermal, donor1	11269-116G9	5.17	0.94	0.47	0.70	0.00
Fibroblast - Dermal, donor2	11346-117G5	8.96	0.94	1.42	2.83	0.00
Fibroblast - Dermal, donor3	11418-118F5	7.86	2.30	1.33	1.33	0.00
Fibroblast - Dermal, donor4	11450-119A1	10.97	0.57	1.81	1.47	0.23
Fibroblast - Dermal, donor5	11454-119A5	11.86	1.74	2.09	0.87	0.17
Fibroblast - Dermal, donor6	11458-119A9	9.26	0.97	0.97	0.97	0.00
Fibroblast - Gingival, donor1	11237-116D4	7.50	2.08	1.25	1.87	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	8.38	1.57	0.26	0.52	0.00
Fibroblast - Gingival, donor2	11318-117D4	14.36	1.05	0.79	1.58	0.79
Fibroblast - Gingival, donor3	11394-118C8	11.12	1.16	1.93	2.22	0.29
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	9.35	0.00	0.00	2.08	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	7.05	0.70	0.70	1.94	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	8.26	1.71	1.25	1.71	0.31
Fibroblast - Gingival, donor6 (control)	11922-125H5	7.44	1.35	1.22	1.22	0.68
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	6.35	2.12	1.06	0.71	0.71
Fibroblast - Gingival, donor7 (control)	11924-125H7	5.85	1.61	1.90	1.32	0.73
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	9.54	1.77	1.36	1.09	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	7.68	1.21	0.99	0.55	0.55
Fibroblast - Gingival, donor9 (control)	11927-125I1	6.02	1.76	0.73	1.61	0.73
Fibroblast - Lung, donor1	11270-116H1	12.23	0.00	1.36	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	5.97	1.49	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	16.46	1.06	0.42	0.42	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	9.16	6.66	1.67	1.67	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	11.19	1.40	1.40	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	7.56	1.12	0.56	1.68	0.56
Fibroblast - Mammary, donor1	11540-120B1	8.53	2.03	0.00	2.03	0.00
Fibroblast - Mammary, donor2	11620-122A9	11.98	7.99	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	11.91	5.96	0.00	11.91	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	12.22	0.78	0.97	2.33	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	16.69	1.37	0.61	0.61	0.46
Fibroblast - Periodontal Ligament, donor3	11395-118C9	5.51	2.14	2.14	1.22	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	3.05	0.38	2.67	0.76	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	6.48	1.89	1.08	0.54	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	6.61	1.04	0.70	1.04	0.23
Fibroblast - Pulmonary Artery, donor1	11250-116E8	9.51	1.55	0.66	1.44	0.44
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	9.55	2.64	1.83	1.02	0.41
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	13.36	2.00	1.34	2.67	1.34
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	8.70	3.95	1.98	1.98	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	6.75	1.98	0.79	0.99	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	2.13	2.66	0.71	0.71	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	4.73	3.94	1.97	1.38	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	3.01	0.90	1.50	0.90	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	3.89	1.94	0.32	0.22	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	3.80	2.02	1.52	0.51	0.00
Fibroblast - skin normal, donor1	11553-120C5	3.45	1.15	1.31	0.82	0.49
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	7.42	1.20	1.60	1.40	0.60
Fibroblast - skin normal, donor2	11561-120D4	3.21	1.31	0.80	1.00	0.30
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	6.04	2.42	1.51	0.60	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	6.54	1.74	1.24	1.08	0.17
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	6.33	2.56	1.88	0.51	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	3.94	4.93	0.66	0.66	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	4.05	1.81	1.07	0.43	0.32
Fibroblast - skin walker warburg, donor1	11554-120C6	6.24	2.19	1.18	1.86	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	4.08	0.78	0.16	0.16	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	8.72	3.49	0.87	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	7.63	0.87	1.73	0.69	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	6.51	2.60	2.08	1.04	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	2.30	1.02	1.28	0.51	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	13.01	1.53	0.77	3.06	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	17.23	2.55	3.19	2.55	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	16.83	0.86	2.28	1.71	0.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	16.27	1.93	1.38	3.03	1.65
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	13.93	1.83	1.60	3.20	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	14.46	2.18	1.98	3.37	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	13.22	2.64	1.32	2.64	2.64
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	17.29	2.28	1.30	1.96	1.30
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	9.29	1.33	2.65	0.88	1.33
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	12.86	1.41	1.55	1.55	0.42
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	15.27	2.34	2.96	1.35	0.49
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	11.55	1.88	2.42	1.34	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	13.26	1.36	1.24	1.24	0.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	12.46	0.69	0.42	1.94	0.28
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	7.93	0.81	1.42	1.02	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	11.87	1.83	1.37	1.60	0.68
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	9.59	2.74	1.00	1.49	0.62
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	9.18	1.53	1.31	1.09	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	17.14	2.95	0.89	2.07	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	13.35	1.43	2.38	2.07	0.79
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	9.83	1.79	2.46	2.46	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	12.50	3.02	3.02	3.02	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	16.79	1.70	2.37	1.19	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	12.59	2.57	2.93	2.31	0.98
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	17.48	3.33	1.77	2.91	0.94
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	12.81	3.24	2.56	2.39	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	14.38	1.33	1.77	1.33	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	13.15	2.66	2.58	1.91	1.16
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	14.91	1.84	1.63	1.23	1.02
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	16.92	1.44	2.06	3.09	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	16.14	1.96	2.54	1.84	0.46
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	14.01	2.00	1.33	1.50	0.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	11.02	2.87	1.98	2.87	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	17.46	3.44	3.20	2.34	0.98
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	12.64	2.11	1.62	1.62	0.65
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	12.51	2.57	2.25	2.89	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	11.75	1.61	1.52	0.85	0.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	11.71	2.37	2.69	2.06	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	12.47	1.22	0.00	3.04	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	13.49	1.67	1.88	1.78	0.42
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	10.32	1.98	2.85	1.98	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	9.54	2.24	2.81	0.56	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	11.30	2.13	1.39	1.39	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	12.57	0.80	1.60	2.14	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	10.25	1.99	2.45	1.68	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	16.84	3.11	1.68	1.94	0.52
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	10.03	3.80	1.63	2.44	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	15.49	2.95	2.58	0.92	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	16.45	3.07	1.97	1.32	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	4.96	2.98	3.97	3.97	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	10.82	2.64	1.98	2.51	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	11.90	1.41	1.61	1.61	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	11.95	4.07	5.59	2.80	0.76
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	8.96	1.79	2.99	0.80	0.40
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	14.02	0.77	2.31	2.47	0.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	16.57	2.25	2.25	2.45	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	13.14	0.94	2.50	2.19	2.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	8.19	0.85	2.26	2.54	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	11.07	1.84	2.31	1.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	14.85	0.00	0.00	2.47	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	7.35	1.16	2.71	1.55	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	19.25	1.60	1.60	1.60	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	6.96	0.00	5.22	5.22	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	8.46	0.33	2.60	1.30	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	8.65	2.47	2.47	1.24	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	23.33	0.00	6.66	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	12.30	1.40	1.96	0.84	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	9.15	1.31	0.65	0.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	18.45	0.84	5.03	3.36	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	15.27	2.23	1.91	0.64	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	6.79	1.70	1.36	1.70	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	12.53	2.09	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	9.74	0.00	0.00	1.15	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	9.18	0.59	1.18	2.07	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	6.78	1.69	6.78	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	12.84	2.07	2.07	0.83	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	10.82	1.15	1.84	2.30	0.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	15.81	5.27	0.00	0.00	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	10.76	0.77	2.31	1.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	8.15	1.30	1.63	0.65	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	7.36	0.67	3.34	0.67	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	9.63	1.54	0.77	0.77	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	18.49	2.05	3.42	1.03	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	27.33	4.97	2.48	2.48	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	10.38	1.42	0.94	1.89	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	15.69	1.81	0.00	1.81	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	14.24	3.05	0.00	2.03	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	11.17	1.20	1.60	1.60	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	15.29	2.96	2.96	2.96	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	16.53	3.54	5.90	0.00	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	8.17	1.75	2.33	1.75	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	15.36	1.32	0.88	2.63	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	14.41	3.39	3.39	5.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	12.54	0.60	2.39	1.79	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	10.19	2.91	2.43	0.00	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	4.57	0.00	0.00	1.14	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	6.65	1.25	1.25	2.08	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	9.00	0.00	0.00	1.12	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	3.81	1.27	1.27	0.63	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	3.34	2.92	0.84	0.84	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	4.53	1.16	1.04	0.35	0.35
Hep-2 cells mock treated, biol_rep2	11899-125E9	6.08	1.35	0.68	1.01	0.51
Hep-2 cells mock treated, biol_rep3	11900-125F1	6.60	1.59	0.68	1.14	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	6.34	1.20	0.66	1.53	0.55
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	5.59	2.15	1.07	0.64	0.86
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	6.67	2.58	0.86	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	4.61	0.50	0.37	1.12	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	4.46	0.86	0.34	0.34	0.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	5.13	0.96	0.96	0.32	0.64
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	5.60	3.92	3.36	1.68	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	10.82	3.90	2.16	1.30	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	21.15	2.64	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	9.17	2.47	2.12	3.17	1.06
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	13.80	2.18	2.18	1.45	1.45
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	10.32	1.05	1.92	0.87	0.00
Hepatocyte, donor1	11523-119I2	12.11	0.00	3.63	0.00	0.00
Hepatocyte, donor2	11603-120I1	18.31	1.08	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	8.59	1.23	3.68	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	26.76	3.26	3.92	1.96	1.96
Intestinal epithelial cells (polarized), donor1	11246-116E4	12.76	0.52	2.97	2.62	0.87
Iris Pigment Epithelial Cells, donor1	11530-119I9	4.94	0.69	0.96	0.69	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	22.29	3.18	6.37	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	20.03	0.00	6.68	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	23.53	1.38	0.00	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	12.51	5.01	0.00	2.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	11.87	11.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	30.75	2.56	0.00	2.56	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	27.42	0.00	9.14	4.57	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	24.36	8.12	1.62	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	18.34	5.00	1.67	3.33	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	25.41	3.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	30.44	6.62	3.97	1.32	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	14.41	2.22	1.11	2.22	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	15.71	5.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	26.45	5.67	0.00	0.00	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	17.01	3.09	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	14.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	24.55	3.88	1.29	0.65	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	17.71	3.22	3.22	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00	11.95	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	25.26	3.26	2.44	1.63	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	29.39	3.78	2.52	2.94	1.68
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	24.11	1.61	4.02	1.61	2.41
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	18.47	1.85	0.92	1.85	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	45.24	15.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	24.55	0.47	1.89	1.42	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	18.14	3.63	2.72	1.81	1.81
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	44.23	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	43.04	6.46	2.15	2.15	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	20.33	1.27	1.27	2.54	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	16.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	22.96	5.10	2.55	0.00	1.28
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	30.99	0.00	3.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	15.80	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	30.70	6.43	4.28	1.43	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	23.23	13.27	3.32	3.32	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	15.43	3.09	1.23	1.23	0.93
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	22.83	5.27	0.00	0.00	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	25.15	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	18.08	4.17	4.17	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	22.13	6.64	0.00	2.21	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	9.73	3.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	26.16	3.49	2.62	2.62	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	27.00	4.50	2.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	24.39	10.45	3.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	33.07	3.20	5.33	4.27	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	12.47	5.54	1.39	2.77	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	11.40	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	19.33	0.00	1.84	3.68	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	15.13	3.03	6.05	3.03	6.05
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	43.46	0.00	0.00	6.21	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	34.89	2.11	1.06	2.11	1.06
Keratinocyte - epidermal, donor1	11272-116H3	4.57	1.96	2.12	1.47	0.73
Keratinocyte - epidermal, donor2	11349-117G8	6.44	2.34	1.17	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	10.41	1.14	1.51	1.80	0.19
Keratinocyte - oral, donor1	11251-116E9	7.95	2.72	1.36	2.04	0.23
Keratocytes, donor1	11527-119I6	11.35	2.41	2.75	2.75	0.00
Keratocytes, donor2	11607-120I5	9.37	1.17	1.17	1.17	0.00
Keratocytes, donor3	11688-122I5	10.28	2.57	0.99	1.58	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	13.19	0.00	2.20	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	7.55	0.00	1.08	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	7.04	1.96	1.50	1.85	0.46
Lens Epithelial Cells, donor3	11690-122I7	3.03	1.92	1.11	1.31	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	8.42	0.83	0.71	1.19	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	7.81	0.56	0.28	0.84	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	8.50	0.31	0.63	0.79	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	10.22	0.54	1.08	1.08	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	4.73	0.32	0.63	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	8.30	1.19	0.65	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	5.75	1.64	0.00	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	9.61	0.76	0.51	0.25	0.76
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	9.99	0.99	0.56	0.84	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	7.52	0.79	1.19	0.40	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	9.69	1.16	1.16	0.58	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	7.96	0.93	0.74	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	6.62	0.70	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	10.50	0.48	0.24	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	9.06	0.69	0.96	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	5.85	1.54	0.62	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	7.48	2.49	0.31	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	9.70	0.73	0.55	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	7.24	0.00	0.66	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	11.13	0.88	0.00	0.88	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	8.96	0.50	0.75	0.75	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	11.64	0.48	0.48	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	6.73	0.81	0.81	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	8.02	0.61	1.06	0.30	0.45
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	5.70	1.04	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	7.54	0.84	0.63	0.84	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	8.27	0.75	0.60	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	9.63	1.38	1.38	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	6.77	1.32	0.56	1.32	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	9.01	0.42	0.64	0.32	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	9.21	0.00	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	8.27	0.00	0.66	0.66	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	7.31	1.61	0.62	0.37	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	6.66	2.22	0.37	0.74	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	6.18	0.99	0.74	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	6.60	0.82	0.69	0.96	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	8.36	0.64	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	8.52	1.22	0.61	1.52	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	7.42	0.56	0.28	0.42	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	9.60	1.07	0.00	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	5.82	1.45	1.45	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	6.38	0.78	0.47	0.47	0.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	8.24	0.36	0.72	1.07	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	6.53	0.98	0.33	0.65	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	9.18	0.94	0.47	0.47	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	8.42	1.61	0.99	1.49	0.50
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	10.76	0.77	0.51	1.28	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	5.07	1.79	0.00	0.30	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	20.39	4.53	4.53	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	18.41	3.84	3.07	2.30	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	28.20	4.45	3.71	2.23	1.48
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	21.16	4.65	3.81	1.69	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	21.80	2.81	4.22	2.11	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	17.75	4.67	1.87	0.93	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	16.49	5.15	1.55	1.55	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	19.03	4.76	2.38	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	22.85	4.30	2.71	1.81	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	18.32	3.78	1.74	2.04	0.87
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	20.26	2.70	1.80	1.80	1.35
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	26.69	4.34	3.79	4.06	1.76
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	20.54	6.68	6.16	2.05	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	17.64	3.88	2.82	1.41	1.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	15.33	3.33	2.00	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	15.79	2.04	3.57	2.04	2.04
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	20.81	3.47	2.67	1.87	0.80
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	22.86	2.65	3.59	1.89	0.57
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	27.00	7.98	1.23	4.29	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	32.62	1.63	3.26	2.45	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	22.49	3.54	2.08	1.87	1.04
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	21.58	5.04	2.52	0.84	1.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	36.06	8.24	2.06	1.03	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	27.00	3.77	3.19	0.87	0.87
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	21.82	2.99	2.99	1.49	1.20
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	17.70	4.98	3.87	1.11	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	30.40	6.01	5.66	2.47	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	15.49	2.58	5.90	0.74	1.48
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	31.08	4.61	0.00	6.91	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	29.93	6.52	5.37	1.15	1.15
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	28.87	8.49	2.26	1.70	1.70
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	29.54	4.92	4.92	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	24.40	5.87	2.26	0.90	1.36
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	17.24	2.15	5.03	1.44	1.44
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	24.65	8.22	4.48	1.49	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	35.67	5.20	1.86	2.23	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	24.12	2.15	2.15	3.02	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	17.13	3.43	1.71	1.71	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	28.32	4.33	3.33	2.00	2.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	21.72	7.24	5.43	1.81	1.81
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	25.60	2.84	6.40	1.42	2.13
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	34.37	2.41	4.12	2.75	1.03
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	20.93	8.05	8.05	0.54	1.07
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	25.59	2.69	2.69	0.00	2.02
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	29.63	5.56	5.19	1.85	1.11
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	18.61	2.33	1.16	2.33	3.49
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	32.79	4.23	2.12	4.23	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	28.81	10.80	4.40	2.40	3.60
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	25.44	4.36	3.63	2.91	2.18
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	23.76	3.07	2.30	1.53	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	22.20	5.92	6.91	1.97	1.48
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	27.29	2.82	9.41	2.82	1.88
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	22.12	1.01	6.54	2.01	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	25.23	1.35	3.15	2.70	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	24.10	6.88	1.72	1.72	3.44
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	32.96	4.90	4.45	2.23	2.23
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	29.33	4.30	5.87	3.13	2.35
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	23.75	4.62	2.64	2.64	1.32
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	29.58	3.11	6.23	1.56	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	31.50	3.50	1.31	3.06	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	16.77	2.80	2.80	1.68	2.24
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	23.41	3.97	5.74	1.77	1.32
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	30.09	4.63	1.16	1.54	0.77
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	24.31	7.09	1.52	3.54	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	23.07	3.84	3.84	3.84	0.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	25.44	5.96	3.98	2.39	1.19
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	23.09	6.08	3.04	0.61	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	18.68	4.84	3.46	2.08	2.77
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	23.56	3.80	2.28	1.14	3.04
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	30.47	4.13	5.68	1.03	1.55
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	28.42	5.44	2.42	3.63	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	35.49	3.17	2.85	3.17	1.90
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	35.18	5.86	2.13	2.13	1.07
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	21.26	5.17	6.32	1.72	1.72
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	34.45	8.74	4.63	0.51	1.54
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	29.71	6.37	4.24	3.54	1.41
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	28.94	7.38	4.54	1.70	1.70
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	30.37	6.66	3.74	2.50	2.08
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	32.10	10.18	3.13	3.13	1.57
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	25.47	6.26	4.18	1.25	0.84
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	31.13	7.90	2.79	1.86	0.93
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	16.06	8.03	4.01	0.67	2.01
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	26.20	5.35	4.28	5.88	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	36.37	4.04	4.04	2.83	3.23
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	24.78	6.42	4.59	1.84	2.75
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	22.23	3.56	2.67	0.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	35.33	3.99	2.85	2.28	2.85
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	22.24	3.83	5.37	0.77	1.53
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	23.53	4.38	4.38	0.55	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	34.30	7.57	2.23	3.56	3.12
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	33.27	6.24	4.42	4.42	1.30
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	23.87	6.63	7.96	3.98	2.65
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	27.02	6.24	6.24	4.16	0.00
Macrophage - monocyte derived, donor1	11232-116C8	5.70	0.23	1.60	1.14	0.23
Macrophage - monocyte derived, donor2	11313-117C8	6.24	1.10	0.92	1.28	0.00
Macrophage - monocyte derived, donor3	11389-118C3	9.18	1.18	0.52	0.92	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	3.72	1.06	0.53	0.00	0.53
Mallassez-derived cells, donor2	11929-125I3	3.49	2.69	0.48	0.79	0.48
Mallassez-derived cells, donor3	11930-125I4	4.73	2.36	0.69	0.69	0.00
Mammary Epithelial Cell, donor1	11273-116H4	5.28	1.10	1.49	1.69	0.30
Mammary Epithelial Cell, donor2	11350-117G9	4.63	2.61	2.61	1.16	0.00
Mammary Epithelial Cell, donor3	11422-118F9	7.98	0.75	1.75	1.50	0.50
Mast cell - stimulated, donor1	11487-119E2	4.75	4.07	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	12.00	3.14	0.87	0.76	0.76
Mast cell, donor2	11565-120D8	22.59	6.54	2.38	1.49	0.89
Mast cell, donor3	11566-120D9	29.27	2.48	2.03	2.03	0.68
Mast cell, donor4	11567-120E1	22.69	3.55	0.89	1.77	1.06
Mast cell, expanded and stimulated, donor5	11940-126A5	15.19	2.77	1.00	0.67	0.55
Mast cell, expanded and stimulated, donor8	11942-126A7	7.00	5.25	0.58	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	16.98	1.95	1.61	1.61	1.03
Mast cell, expanded, donor8	11941-126A6	14.73	2.34	1.34	1.34	1.00
Melanocyte - dark, donor1	11502-119F8	11.54	1.49	0.80	1.49	0.30
Melanocyte - dark, donor2	11582-120F7	10.04	2.08	0.69	0.69	0.35
Melanocyte - dark, donor3	11663-122F7	7.53	0.94	3.19	1.88	0.14
Melanocyte - light, donor1	11274-116H5	7.05	1.41	1.41	1.65	0.00
Melanocyte - light, donor2	11351-117H1	6.82	2.05	2.05	2.73	0.00
Melanocyte - light, donor3	11423-118G1	13.01	1.73	2.60	4.34	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	16.14	1.25	2.60	1.67	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	9.14	0.54	1.61	1.08	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	8.84	2.14	1.87	2.14	0.27
Meningeal Cells, donor1	11493-119E8	9.43	1.49	1.98	1.98	0.74
Meningeal Cells, donor2	11573-120E7	7.48	0.88	1.32	0.88	0.00
Meningeal Cells, donor3	11654-122E7	12.88	1.30	2.61	1.47	0.73
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	7.98	2.00	0.86	2.57	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	5.23	1.51	1.71	0.30	0.81
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	3.94	0.00	6.57	3.94	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	15.70	1.31	2.62	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	13.63	1.44	0.72	2.15	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	5.93	1.69	1.69	1.27	0.64
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	9.05	1.01	0.50	0.50	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	10.99	1.76	1.98	2.64	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	18.26	2.19	3.65	1.46	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	13.30	3.27	1.43	2.25	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	3.32	1.80	1.94	0.83	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	5.95	2.60	2.60	1.49	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	6.05	1.84	1.45	1.45	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	4.75	4.45	1.48	1.19	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	11.68	4.67	0.00	4.67	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	8.33	1.28	1.92	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	10.63	0.71	0.35	1.77	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	2.50	0.94	1.88	1.56	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	12.34	2.18	0.00	1.45	0.00
Mesothelial Cells, donor1	11247-116E5	3.71	2.65	0.53	0.27	0.27
Mesothelial Cells, donor2	12156-128G5	3.50	0.50	0.50	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	5.93	1.59	1.08	0.79	0.29
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	5.40	0.00	1.35	1.35	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	10.34	0.49	0.99	1.72	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	9.72	1.18	1.18	0.88	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	13.83	6.91	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	3.72	1.55	1.24	0.93	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	7.88	0.21	0.21	0.00	0.62
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	6.95	0.00	0.00	2.32	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	8.01	0.75	0.75	0.75	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	4.19	1.86	0.47	1.40	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	5.69	0.81	0.41	1.22	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	9.11	1.19	2.38	0.79	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	25.65	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	4.42	0.88	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	6.84	0.38	0.38	1.14	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	6.58	1.32	1.32	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	6.58	0.64	0.42	0.42	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	2.76	0.00	0.92	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	3.87	0.30	0.60	0.30	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	3.35	0.00	3.35	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	3.76	0.00	0.25	0.50	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	5.23	1.66	0.24	0.71	0.48
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	2.21	0.00	0.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	2.99	0.23	0.00	0.46	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	4.00	0.84	0.21	0.63	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	3.87	0.41	0.20	0.20	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	4.29	0.43	0.00	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	5.33	0.22	0.22	0.44	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	3.07	0.44	1.10	0.44	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	2.53	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	6.63	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	3.26	0.00	0.82	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	3.53	0.00	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	3.27	0.00	1.09	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	2.88	0.00	0.48	0.48	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	4.80	0.00	1.20	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	4.11	0.00	0.00	0.00	1.37
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	6.51	0.00	0.50	1.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	4.08	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	3.94	0.00	0.00	0.00	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	0.00	2.21	0.00	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	3.84	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	6.94	0.50	0.74	1.24	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	5.57	0.70	0.00	0.00	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	11.05	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	6.50	1.03	0.00	0.68	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	4.81	0.00	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	4.26	0.00	0.36	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	5.89	1.12	0.56	0.28	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	5.82	0.83	0.83	0.42	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	2.91	0.00	1.17	0.00	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	6.03	1.21	0.90	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	5.43	1.67	1.67	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	7.22	7.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	4.62	0.92	1.85	0.92	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	6.83	0.57	0.57	1.14	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	4.01	0.28	0.14	0.14	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	4.92	0.00	0.78	0.26	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	6.86	1.29	2.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	6.35	0.64	1.91	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	3.47	0.80	1.07	0.53	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	4.49	0.90	0.30	1.20	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	3.81	0.71	0.71	0.14	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	4.78	0.32	0.32	0.64	0.64
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	7.74	0.88	1.99	0.66	0.66
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	3.79	0.38	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	6.25	0.57	0.28	0.28	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	6.39	0.25	2.21	0.74	0.49
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	3.91	0.65	0.00	1.30	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	5.59	0.88	0.88	0.29	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	7.78	0.29	0.00	1.44	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	5.36	1.65	0.82	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	5.36	0.60	0.60	0.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	11.30	3.77	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	3.56	1.78	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	12.16	1.31	1.31	0.33	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	13.68	2.10	0.00	2.10	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	9.29	0.79	1.78	0.99	0.79
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	7.45	0.93	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	4.51	0.75	1.50	1.50	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	10.39	1.60	0.80	0.80	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	5.88	0.11	1.24	1.24	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	9.58	0.00	1.47	0.74	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	9.53	0.73	1.83	1.83	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	7.78	0.00	1.56	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	3.21	0.00	0.00	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	7.73	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	10.10	0.00	1.01	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	4.64	0.42	0.42	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	1.36	0.00	1.36	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	0.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.81	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	3.02	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	11.42	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	9.79	0.00	3.26	0.00	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	25.10	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	5.60	2.37	1.94	1.72	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	5.75	2.61	3.14	2.09	1.05
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	3.34	2.00	1.33	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	4.17	1.25	0.00	1.25	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	4.18	0.95	0.57	0.19	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	3.19	3.19	1.60	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	0.68	0.68	2.04	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	1.84	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	3.35	2.09	1.67	0.42	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	4.18	0.70	1.39	0.70	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	3.78	0.81	1.35	1.08	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	6.10	1.05	1.26	0.63	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	5.46	0.99	0.50	0.50	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	5.41	1.08	1.08	0.81	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	3.63	0.91	1.13	0.45	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	3.59	0.65	1.63	1.14	0.49
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	3.28	2.55	2.00	0.55	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	3.71	0.53	0.53	1.06	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	2.40	0.60	1.20	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	2.63	1.31	0.33	0.98	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	4.72	1.30	1.14	0.65	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	3.17	1.06	1.23	0.71	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	4.22	1.41	0.70	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	5.06	0.92	0.92	0.92	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	6.11	1.29	1.93	0.96	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	4.48	0.69	0.34	0.00	1.03
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	5.06	0.00	0.00	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	3.12	1.34	2.01	0.22	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	2.96	1.27	2.54	0.42	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	2.85	0.95	0.95	0.71	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	3.86	2.15	1.29	1.29	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	3.00	1.67	1.33	1.33	0.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	7.66	0.45	0.45	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	2.78	1.98	0.00	1.98	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	1.86	0.00	1.86	1.86	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	3.03	0.38	1.51	1.51	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	1.30	2.61	1.96	0.98	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	1.74	1.31	2.61	0.87	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	2.26	1.81	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	4.41	1.76	1.76	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	9.31	3.32	0.00	1.33	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	2.98	1.49	0.00	0.50	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	1.15	0.77	1.91	0.77	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	3.93	2.42	3.02	1.21	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	2.65	1.77	1.55	0.66	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	4.07	2.71	0.68	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	8.54	0.61	2.44	1.83	1.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	2.52	0.63	0.31	0.63	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	4.84	0.91	0.91	0.91	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	3.16	0.79	2.37	0.00	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	6.80	1.13	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	0.00	5.06	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	4.47	1.74	0.87	0.62	0.37
Myoblast, donor2	11322-117D8	6.90	2.11	1.15	0.96	0.00
Myoblast, donor3	11398-118D3	3.20	0.84	1.51	1.35	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	11.53	1.46	2.48	2.48	0.44
Natural Killer Cells, donor1	11230-116C6	43.67	3.69	2.46	4.31	0.62
Natural Killer Cells, donor2	11311-117C6	53.98	3.32	2.41	2.71	1.51
Natural Killer Cells, donor3	11387-118C1	52.46	2.58	2.02	4.23	0.74
Neural stem cells, donor1	11275-116H6	11.98	5.08	1.81	2.54	1.09
Neural stem cells, donor2	11352-117H2	21.18	5.78	1.93	1.93	3.85
Neurons, donor1	11494-119E9	29.59	11.38	4.55	3.41	3.41
Neurons, donor2	11574-120E8	24.44	2.42	3.30	3.30	4.62
Neurons, donor3	11655-122E8	18.09	8.22	4.93	2.47	2.47
Neutrophils, donor1	11233-116C9	15.78	0.93	3.71	0.00	0.93
Neutrophils, donor2	11314-117C9	26.09	0.00	0.00	2.90	0.00
Neutrophils, donor3	11390-118C4	19.55	0.00	0.61	2.44	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	7.84	2.14	1.54	1.66	0.24
Nucleus Pulposus Cell, donor2	11409-118E5	6.84	3.26	0.98	2.28	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	5.01	1.00	2.61	1.20	0.40
Olfactory epithelial cells, donor1	11933-125I7	5.37	1.10	1.51	0.55	0.41
Olfactory epithelial cells, donor2	11934-125I8	6.08	1.01	0.72	0.58	0.43
Olfactory epithelial cells, donor3	11935-125I9	5.90	1.48	1.48	1.02	0.23
Olfactory epithelial cells, donor4	11936-126A1	5.45	1.75	0.88	1.75	0.29
Oligodendrocyte - precursors, donor1	11496-119F2	7.82	0.60	0.00	3.01	0.00
Osteoblast - differentiated, donor1	11276-116H7	3.40	2.77	1.28	0.43	0.21
Osteoblast - differentiated, donor2	11353-117H3	2.29	3.43	2.29	2.29	1.14
Osteoblast - differentiated, donor3	11425-118G3	10.55	3.10	2.48	2.48	0.62
Osteoblast, donor1	11277-116H8	8.01	2.35	2.35	1.95	0.39
Osteoblast, donor2	11354-117H4	6.32	4.21	2.11	1.40	0.70
Osteoblast, donor3	11426-118G4	9.60	1.07	2.13	1.07	0.36
Pancreatic stromal cells, donor1	11249-116E7	6.49	1.01	1.01	1.01	0.17
Pericytes, donor1	11491-119E6	5.90	3.34	3.89	2.67	0.78
Pericytes, donor2	11571-120E5	6.79	2.49	2.49	2.94	0.45
Pericytes, donor3	11652-122E5	5.70	1.42	1.22	1.42	0.41
Perineurial Cells, donor1	11499-119F5	5.09	0.34	1.24	1.02	0.11
Perineurial Cells, donor2	11579-120F4	7.64	1.47	1.47	2.02	0.28
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	27.09	3.19	2.23	3.19	1.59
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	34.04	0.98	1.96	0.49	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	38.18	2.33	1.81	2.59	1.29
Placental Epithelial Cells, donor1	11278-116H9	18.65	3.11	5.74	3.83	0.72
Placental Epithelial Cells, donor2	11355-117H5	13.31	2.22	6.65	2.22	2.22
Placental Epithelial Cells, donor3	11427-118G5	17.08	1.18	1.96	0.98	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	10.44	1.27	4.11	2.22	0.32
Preadipocyte - breast, donor1	11467-119B9	3.00	1.13	1.69	0.56	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	6.00	2.22	1.83	1.17	0.00
Preadipocyte - breast, donor2	11328-117E5	7.88	2.48	2.93	2.25	0.23
Preadipocyte - omental, donor1	11468-119C1	5.22	2.02	1.81	1.28	0.32
Preadipocyte - omental, donor2	11329-117E6	6.11	1.31	0.87	1.31	0.00
Preadipocyte - omental, donor3	11403-118D8	4.58	2.29	1.86	1.43	0.14
Preadipocyte - perirenal, donor1	11469-119C2	2.95	2.95	3.94	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	5.84	1.84	2.15	1.54	0.61
Preadipocyte - subcutaneous, donor2	11356-117H6	12.40	2.66	1.77	1.59	0.89
Preadipocyte - subcutaneous, donor3	11428-118G6	10.22	1.70	1.36	1.53	0.17
Preadipocyte - visceral, donor1	11280-116I2	7.27	2.14	1.40	1.68	0.47
Preadipocyte - visceral, donor2	11357-117H7	8.74	0.46	0.46	0.46	0.46
Preadipocyte - visceral, donor3	11429-118G7	6.16	1.99	1.15	0.84	0.42
Prostate Epithelial Cells (polarized), donor1	11253-116F2	13.58	2.11	3.17	0.91	0.91
Prostate Epithelial Cells, donor2	11331-117E8	4.74	1.35	1.22	0.95	0.14
Prostate Epithelial Cells, donor3	11404-118D9	5.63	0.92	1.41	1.22	0.24
Prostate Stromal Cells, donor1	11254-116F3	7.75	0.57	0.91	1.25	0.34
Prostate Stromal Cells, donor2	11332-117E9	7.89	0.72	1.08	0.90	0.00
Prostate Stromal Cells, donor3	11405-118E1	7.30	0.73	1.15	1.04	0.63
Renal Cortical Epithelial Cells, donor1	11516-119H4	10.22	0.73	2.92	1.46	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	8.59	1.04	0.83	1.18	0.35
Renal Epithelial Cells, donor1	11517-119H5	17.75	3.04	2.03	2.03	0.00
Renal Epithelial Cells, donor2	11597-120H4	10.67	0.00	0.71	0.71	0.00
Renal Epithelial Cells, donor3	11678-122H4	8.36	1.80	1.80	1.48	0.64
Renal Glomerular Endothelial Cells, donor1	11514-119H2	12.94	0.68	3.40	1.36	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	8.22	2.02	1.75	0.54	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	9.55	1.11	1.11	0.22	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	13.31	2.66	2.00	5.32	0.00
Renal Mesangial Cells, donor1	11518-119H6	8.14	2.86	1.98	1.76	1.32
Renal Mesangial Cells, donor2	11598-120H5	8.15	6.27	1.88	3.76	1.25
Renal Mesangial Cells, donor3	11679-122H5	12.21	2.77	0.83	2.22	1.11
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	11.27	1.88	1.61	1.07	0.54
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	12.23	1.27	0.84	1.27	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	16.20	1.93	1.74	1.35	0.58
Retinal Pigment Epithelial Cells, donor0	11215-116A9	4.67	0.78	1.30	2.07	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	7.67	2.27	0.85	2.56	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	16.47	0.00	4.12	2.06	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	5.77	1.51	2.51	2.01	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	13.10	1.74	1.60	1.47	0.27
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	5.36	0.89	1.79	0.89	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	4.95	2.20	1.10	0.55	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	5.22	1.74	4.06	1.16	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	4.94	0.78	2.08	0.52	0.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	7.65	0.89	2.68	1.09	0.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	9.59	0.45	1.90	2.01	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	10.42	0.99	2.23	1.24	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	10.14	0.82	1.75	1.05	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	9.94	1.39	2.08	1.16	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	8.49	1.10	1.78	0.68	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	12.10	0.91	1.36	0.45	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	8.60	1.25	2.15	1.25	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	8.32	1.15	2.30	1.29	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	10.62	1.18	2.15	1.29	0.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	9.29	1.99	2.21	1.11	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	7.65	1.34	1.34	0.38	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	8.48	0.75	1.30	1.21	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	8.83	0.94	1.88	1.50	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	6.77	0.80	2.39	0.80	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	8.96	0.29	1.95	0.88	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	12.22	1.15	1.53	1.15	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	7.48	1.39	1.50	0.85	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	12.61	0.56	1.96	0.56	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	8.20	0.68	3.08	0.51	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	9.12	0.55	2.37	1.28	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	10.67	0.86	1.47	1.84	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	12.76	1.34	1.88	1.21	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	14.15	2.12	2.36	0.94	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	9.92	0.00	2.58	0.79	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	13.10	0.47	1.87	1.17	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	13.06	1.66	2.07	3.11	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	6.86	0.88	1.55	0.44	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	8.56	2.92	2.09	0.42	0.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	12.52	1.08	2.96	1.35	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	10.22	0.85	1.87	1.87	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	11.57	2.51	2.70	2.31	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	12.90	1.38	2.75	1.38	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	10.42	1.51	1.37	1.37	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	11.66	1.31	2.79	1.97	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	9.20	1.19	1.19	1.02	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	10.36	0.74	1.92	1.04	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	10.13	1.33	1.60	0.00	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	10.78	0.28	2.63	1.80	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	10.71	1.19	1.43	1.67	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	12.29	2.02	1.41	1.61	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	8.76	0.94	3.01	1.79	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	10.13	1.40	2.10	1.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	8.16	0.91	1.51	2.12	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	9.06	1.47	2.33	2.08	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	12.81	1.89	4.22	1.60	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	9.13	2.43	1.83	3.04	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	13.26	0.30	3.01	2.11	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	13.57	1.58	4.30	1.81	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	17.67	2.70	3.00	2.40	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	10.27	0.71	2.60	2.01	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	13.66	0.43	3.63	1.71	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	13.82	0.60	1.80	3.00	0.60
Schwann Cells, donor1	11498-119F4	10.91	1.69	2.44	2.07	0.38
Schwann Cells, donor2	11578-120F3	10.21	0.00	0.00	0.00	3.40
Schwann Cells, donor3	11659-122F3	14.24	1.10	2.19	1.53	0.44
Sebocyte, donor1	11220-116B5	7.12	3.29	2.19	0.55	1.10
Sebocyte, donor2	11301-117B5	5.97	1.84	0.00	0.46	0.46
Sebocyte, donor3	11378-118B1	10.92	2.89	1.86	1.44	0.00
Sertoli Cells, donor1	11255-116F4	4.97	0.00	1.66	1.66	0.00
Sertoli Cells, donor2	11333-117F1	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	11.26	2.38	3.26	2.90	0.88
Skeletal Muscle Cells, donor2	11358-117H8	7.95	1.45	2.17	2.17	0.72
Skeletal Muscle Cells, donor3	11430-118G8	15.88	0.84	1.67	2.51	0.84
Skeletal Muscle Cells, donor4	11451-119A2	9.43	1.26	2.04	0.94	0.31
Skeletal Muscle Cells, donor5	11455-119A6	10.41	0.89	1.93	0.74	0.89
Skeletal Muscle Cells, donor6	11459-119B1	12.93	0.77	0.92	0.62	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	7.56	2.02	0.76	0.88	0.25
Skeletal Muscle Satellite Cells, donor2	11321-117D7	8.42	2.28	1.71	0.86	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	17.66	1.69	2.28	1.79	0.30
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	9.01	2.44	2.95	2.27	0.34
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	16.65	1.45	2.90	2.17	1.45
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	7.29	2.20	2.20	1.51	0.69
Skin - palm, donor1	10286-104F7	5.37	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	4.18	1.30	0.00	0.58	0.43
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	10.63	4.09	1.64	0.82	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	6.62	1.17	0.78	0.65	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	6.67	1.25	0.70	0.83	0.28
Small Airway Epithelial Cells, donor2	11334-117F2	5.63	0.98	0.70	0.42	0.28
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	12.90	2.33	2.54	0.63	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	6.15	0.75	1.20	0.97	0.22
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	4.63	0.62	1.54	0.62	0.62
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	3.11	2.22	1.11	0.22	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	7.64	2.94	1.18	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	5.52	0.88	2.65	1.10	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	3.94	1.18	1.58	0.79	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	5.41	1.55	0.77	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	16.01	1.00	0.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	5.46	1.06	1.20	0.67	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	5.10	1.55	0.66	0.66	0.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	2.05	0.77	0.51	0.90	0.26
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	5.86	0.33	0.33	1.63	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	4.73	1.77	2.36	1.18	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	5.55	0.43	1.14	0.28	0.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	10.41	2.44	1.79	1.63	0.81
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	4.87	0.00	1.22	0.91	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	7.58	2.02	1.01	1.26	0.51
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	36.72	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	5.25	0.00	0.48	0.95	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	6.34	0.74	1.33	1.33	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	9.04	1.51	1.29	1.29	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	7.98	1.26	1.15	1.36	0.10
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	4.64	2.94	2.78	0.93	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	3.23	2.16	2.16	0.00	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	5.08	3.59	1.49	1.79	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	9.22	1.71	1.02	1.37	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	5.03	1.65	1.65	1.10	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	3.72	2.52	1.01	1.21	0.30
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	9.78	2.50	2.05	0.68	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	3.02	1.21	3.02	1.21	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	16.43	0.79	1.59	2.12	1.32
Smooth Muscle Cells - Prostate, donor1	11257-116F6	5.19	0.80	1.73	0.67	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	6.01	1.13	0.63	0.63	0.25
Smooth Muscle Cells - Prostate, donor3	11465-119B7	2.54	0.25	0.76	0.25	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	5.88	1.66	1.21	1.51	0.45
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	3.75	1.50	2.25	0.75	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	5.17	0.00	0.00	1.29	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	11.16	1.40	1.40	0.93	1.40
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	5.05	1.01	0.00	1.01	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	4.70	1.25	1.25	1.25	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	3.83	2.06	1.77	0.88	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	9.33	1.33	1.17	1.08	0.33
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	7.01	0.47	0.93	0.47	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	4.46	1.01	1.15	0.86	0.43
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	10.71	1.78	1.78	2.29	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	5.26	0.75	1.32	0.75	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	7.41	1.12	0.70	1.12	0.28
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	6.12	1.84	1.59	1.68	0.34
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	13.33	5.24	0.95	3.81	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	4.40	1.47	0.24	1.22	0.49
Smooth Muscle Cells - Uterine, donor1	11258-116F7	4.20	2.21	1.33	1.55	0.44
Smooth Muscle Cells - Uterine, donor3	11466-119B8	9.07	1.76	1.17	0.59	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	4.66	0.97	0.97	1.94	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	2.64	1.85	0.53	0.53	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	1.49	1.86	0.74	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	3.59	0.72	1.08	1.08	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	4.83	2.27	1.70	0.28	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	6.70	0.79	1.18	0.79	1.18
Smooth muscle cells - airway, control, donor1	11966-126D4	2.03	1.78	0.00	0.25	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	2.00	0.80	0.80	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	2.09	1.67	0.84	0.42	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	5.04	0.92	1.83	0.92	0.92
Synoviocyte, donor1	11291-117A4	9.09	2.02	1.35	1.18	0.67
Synoviocyte, donor2	11368-117I9	6.87	1.01	1.17	1.01	0.50
Synoviocyte, donor3	11440-118H9	3.57	1.56	0.89	0.22	0.45
Trabecular Meshwork Cells, donor1	11532-120A2	15.37	3.22	2.14	1.07	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	17.84	0.00	3.96	1.98	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	19.91	1.62	1.62	2.08	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	5.45	1.15	1.15	0.93	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	9.28	1.55	1.55	1.16	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	9.16	1.15	0.57	1.15	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	12.06	1.72	2.09	1.48	0.12
Urethra, donor2	10319-105A4	12.59	1.80	1.80	0.00	0.00
Urothelial Cells, donor1	11520-119H8	5.58	1.06	1.59	1.86	0.53
Urothelial Cells, donor2	11600-120H7	5.61	2.40	0.00	0.40	0.00
Urothelial Cells, donor3	11681-122H7	6.19	2.29	0.92	1.60	0.46
Urothelial cells, donor0	11216-116B1	6.69	2.67	1.34	0.67	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	13.35	0.89	1.78	3.56	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	17.16	1.43	2.86	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	27.38	1.37	1.37	0.68	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	19.97	3.10	1.38	2.07	2.07
Whole blood (ribopure), donor090325, donation2	12177-128I8	23.24	1.74	1.74	2.32	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	12.49	1.04	3.12	3.12	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	9.18	0.00	1.84	2.75	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	18.26	0.91	2.74	0.91	0.00
Wilms' tumor cell line:G-401	10809-111A8	11.23	1.73	2.96	2.59	0.62
Wilms' tumor cell line:HFWT	10597-108E3	5.28	1.76	1.76	0.00	1.76
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	12.29	1.40	1.40	0.84	0.28
achilles tendon, donor2	10292-104G4	8.27	6.20	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	21.42	3.57	2.55	3.31	1.02
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	19.50	0.70	2.32	1.16	0.70
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	39.29	3.21	3.32	3.44	1.66
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	23.13	7.89	1.63	3.54	2.45
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	13.49	3.37	3.65	2.81	1.12
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	6.98	0.00	1.27	0.85	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	5.44	1.91	0.82	0.27	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	4.85	1.76	0.88	0.88	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	13.07	3.68	2.04	0.41	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	31.45	5.05	3.88	2.33	1.16
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	13.25	1.29	0.74	1.29	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	23.40	3.90	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	12.32	5.11	2.32	2.32	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	22.52	3.88	4.66	1.04	0.78
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	20.46	4.38	1.46	1.75	2.05
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	7.90	1.39	2.32	0.93	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	4.94	0.00	0.82	0.00	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	11.66	0.00	0.31	0.61	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	13.23	0.43	1.71	0.43	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	11.53	1.21	1.52	0.61	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	15.16	0.48	0.96	0.24	0.72
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	17.15	2.00	1.56	1.56	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	12.34	1.33	0.33	0.33	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	7.43	3.72	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	15.82	2.26	2.26	0.75	1.13
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	18.32	5.23	2.62	1.74	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	1.87	1.87	1.87	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	14.13	0.94	2.83	2.35	0.00
adipose tissue, adult, pool1	10010-101C1	11.32	0.93	0.78	1.40	0.16
adipose, donor1	10184-103D4	16.42	2.35	1.17	0.59	0.59
adipose, donor2	10185-103D5	10.54	0.81	1.62	1.62	0.00
adipose, donor3	10186-103D6	12.80	3.00	1.09	1.36	1.09
adipose, donor4	10187-103D7	13.87	2.60	1.73	2.60	1.73
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	8.05	0.95	1.89	1.74	2.05
adrenal gland, adult, pool1	10081-102A9	3.64	3.64	7.28	3.64	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	10.54	1.60	2.40	2.00	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	13.58	0.71	4.64	1.43	0.36
amniotic membrane cells, donor1	12235-129G3	9.27	2.55	2.32	0.93	0.23
amniotic membrane cells, donor2	12236-129G4	10.48	1.01	1.69	2.37	0.68
amniotic membrane cells, donor3	12237-129G5	5.30	2.36	0.88	1.18	0.00
amygdala - adult, donor10196	10167-103B5	13.04	5.93	2.37	0.00	0.00
amygdala, adult, donor10252	10151-102I7	12.77	2.03	1.42	1.82	0.41
amygdala, newborn, donor10223	10360-105E9	7.42	2.26	1.61	0.97	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	5.22	0.64	1.53	2.04	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	20.08	2.87	3.75	3.31	0.66
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	13.03	0.67	12.36	3.34	0.33
aorta, adult, pool1	10052-101G7	12.16	2.55	0.98	1.18	0.00
appendix, adult	10189-103D9	27.17	1.16	2.72	0.78	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	12.38	3.78	5.16	1.72	0.00
artery, adult	10190-103E1	6.79	1.36	0.00	0.00	1.36
astrocytoma cell line:TM-31	10425-106D2	11.01	1.01	1.45	1.59	0.14
b cell line:RPMI1788	10427-106D4	8.92	1.49	1.93	0.74	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	1.39	0.28	1.39	0.28	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	8.63	0.79	1.49	1.39	0.40
bile duct carcinoma cell line:TFK-1	10496-107C1	8.20	0.33	2.34	1.00	0.67
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	7.27	0.00	0.56	1.68	0.56
bladder, adult, pool1	10011-101C2	13.69	0.87	1.52	1.85	0.43
blood, adult, pool1	10053-101G8	13.29	0.00	0.00	2.21	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	0.86	0.86	0.00	0.00	0.00
bone marrow, adult	10192-103E3	30.37	4.72	5.40	4.05	0.00
brain, adult, donor1	10084-102B3	10.25	4.10	1.03	5.13	0.00
brain, adult, pool1	10012-101C3	8.91	3.79	2.90	0.78	0.11
brain, fetal, pool1	10085-102B4	21.37	5.34	5.34	5.34	0.00
breast carcinoma cell line:MCF7	10482-107A5	16.85	1.98	0.99	2.31	1.65
breast carcinoma cell line:MDA-MB-453	10419-106C5	13.11	2.25	1.87	1.12	1.50
breast, adult, donor1	10080-102A8	12.63	1.89	0.63	1.89	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	8.13	1.65	0.89	1.14	0.64
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	5.88	0.93	0.00	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	2.99	0.23	0.23	0.46	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	10.17	2.42	0.97	1.45	0.24
carcinoid cell line:NCI-H1770	10703-109H1	17.40	3.29	4.23	3.76	0.94
carcinoid cell line:NCI-H727	10735-110B6	5.58	0.11	1.20	0.98	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	4.12	0.63	0.95	0.95	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	13.04	2.93	2.13	1.06	1.60
caudate nucleus - adult, donor10196	10177-103C6	10.36	2.30	5.76	0.00	1.15
caudate nucleus, adult, donor10252	10164-103B2	9.54	3.51	2.68	2.68	0.67
caudate nucleus, adult, donor10258	10379-105H1	11.46	9.93	6.11	2.29	0.00
caudate nucleus, newborn, donor10223	10354-105E3	12.45	4.76	1.10	1.10	0.00
cerebellum - adult, donor10196	10173-103C2	29.13	8.74	2.91	2.91	0.00
cerebellum, adult, donor10252	10166-103B4	16.65	2.99	5.34	2.35	0.00
cerebellum, adult, pool1	10083-102B2	13.45	2.41	2.76	0.69	0.00
cerebellum, newborn, donor10223	10357-105E6	22.42	9.13	1.66	1.66	0.00
cerebral meninges, adult	10188-103D8	8.82	2.52	3.28	2.02	0.25
cerebrospinal fluid, donor2	10294-104G6	3.65	2.92	1.46	0.73	0.00
cervical cancer cell line:D98-AH2	10552-107I3	6.18	1.73	1.44	1.44	0.43
cervical cancer cell line:ME-180	10553-107I4	8.45	0.50	1.99	1.33	1.33
cervix, adult, pool1	10013-101C4	16.27	1.99	1.89	2.20	0.42
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	5.29	2.37	2.09	0.98	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	2.61	0.00	1.31	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	5.84	0.99	0.99	0.75	0.00
choriocarcinoma cell line:SCH	10785-110H2	3.82	0.25	0.74	0.49	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	16.37	0.95	1.19	2.13	0.00
chorionic membrane cells, donor1	12238-129G6	7.98	1.71	0.85	2.28	0.28
chorionic membrane cells, donor2	12239-129G7	6.76	1.09	1.49	1.39	0.30
chorionic membrane cells, donor3	12240-129G8	3.30	0.55	0.55	0.55	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	20.20	5.05	0.00	1.01	2.02
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	13.25	2.69	1.34	1.15	0.58
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	6.55	4.86	1.27	0.84	0.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	9.76	1.80	0.77	0.26	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	8.47	0.97	0.73	0.24	1.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	10.18	2.24	1.22	1.02	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	7.66	1.18	1.18	0.59	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	13.81	1.82	1.82	1.56	0.78
clear cell carcinoma cell line:JHOC-5	10638-108I8	12.11	1.60	0.69	1.37	0.46
clear cell carcinoma cell line:TEN	10636-108I6	4.16	0.69	0.17	0.52	0.17
colon carcinoma cell line:CACO-2	10513-107D9	6.22	1.28	2.20	0.92	0.92
colon carcinoma cell line:COLO-320	10420-106C6	15.58	0.00	2.28	1.52	0.00
colon, adult, donor1	10082-102B1	21.42	3.57	2.38	2.38	1.19
colon, adult, pool1	10014-101C5	13.40	1.41	1.53	1.29	0.12
colon, fetal, donor1	10070-101I7	7.42	2.47	0.00	1.24	0.62
common myeloid progenitor CMP, donor1	12130-128D6	41.25	13.75	13.75	4.58	13.75
common myeloid progenitor CMP, donor2	12134-128E1	75.11	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	17.00	3.40	2.12	0.85	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	8.60	1.66	0.91	1.66	0.45
cord blood derived cell line:COBL-a untreated	10449-106F8	9.87	3.95	0.99	0.85	0.42
corpus callosum, adult, pool1	10042-101F6	19.35	3.76	5.31	3.98	0.88
cruciate ligament, donor2	10295-104G7	9.73	0.81	0.81	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	12.84	1.61	0.80	4.01	0.00
diencephalon, adult	10193-103E4	10.08	4.56	0.96	2.64	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	31.00	2.30	2.30	2.98	0.46
ductal cell carcinoma cell line:KLM-1	10438-106E6	10.26	1.54	3.85	2.31	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	7.46	1.20	5.30	1.20	0.24
ductus deferens, adult	10196-103E7	17.94	3.49	1.00	3.49	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	14.40	1.44	1.44	2.88	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	16.18	1.47	0.74	0.74	0.00
dura mater, adult, donor1	10041-101F5	12.14	0.66	1.07	0.83	0.66
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	16.21	6.22	17.77	4.22	0.89
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	11.89	2.44	3.87	1.29	1.15
embryonic pancreas cell line:1B2C6	10604-108F1	11.72	0.62	2.47	1.85	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	9.99	0.30	1.51	1.21	0.61
embryonic pancreas cell line:1C3IKEI	10606-108F3	12.04	0.62	1.85	1.54	0.31
embryonic pancreas cell line:2C6	10603-108E9	17.08	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	5.03	1.34	2.01	0.34	0.67
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	10.69	1.09	3.08	1.99	0.54
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	11.74	2.25	1.13	0.64	0.48
epidermoid carcinoma cell line:A431	10426-106D3	7.23	0.89	0.89	0.56	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	6.71	0.66	1.32	1.87	0.33
epididymis, adult	10197-103E8	13.61	2.30	0.84	1.47	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	9.76	1.06	1.60	1.42	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	10.62	0.39	1.97	0.79	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	11.79	1.57	1.31	1.97	0.52
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	15.35	1.08	1.87	1.67	0.69
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	14.00	1.68	1.12	0.78	0.45
esophagus, adult, pool1	10015-101C6	10.19	0.64	1.49	1.38	0.21
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	11.90	5.51	1.88	1.88	2.00
eye - muscle inferior rectus, donor1	10272-104E2	9.66	2.41	2.41	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	2.10	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	7.44	1.49	0.00	1.49	1.49
eye - muscle superior, donor2	10297-104G9	5.73	1.15	2.29	2.29	0.00
eye - vitreous humor, donor1	10268-104D7	2.91	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	10.68	1.27	0.51	0.51	0.76
fibrosarcoma cell line:HT-1080	10758-110E2	9.75	2.18	1.15	2.56	0.26
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	10.45	2.37	0.71	0.95	0.71
frontal lobe, adult, pool1	10040-101F4	11.45	5.44	5.35	3.00	0.75
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	10.81	2.10	0.90	1.20	0.90
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	11.06	0.82	0.91	1.37	0.09
gall bladder, adult	10198-103E9	12.31	0.97	0.72	2.90	0.72
gamma delta positive T cells, donor1	11937-126A2	45.10	3.22	2.68	2.15	0.54
gamma delta positive T cells, donor2	11938-126A3	39.22	2.61	4.86	1.12	1.12
gastric adenocarcinoma cell line:MKN1	10614-108G2	14.79	2.32	1.90	2.11	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	23.40	1.74	2.71	3.67	0.39
gastric cancer cell line:AZ521	10549-107H9	7.71	1.48	2.30	1.97	0.82
gastric cancer cell line:GSS	10560-108A2	34.78	2.75	1.83	3.66	2.75
gastrointestinal carcinoma cell line:ECC12	10615-108G3	21.25	2.74	6.63	2.51	0.69
giant cell carcinoma cell line:LU65	10487-107B1	11.02	0.46	2.18	1.26	0.46
giant cell carcinoma cell line:Lu99B	10433-106E1	15.82	2.52	1.26	2.10	0.56
glassy cell carcinoma cell line:HOKUG	10688-109F4	3.74	0.00	0.75	0.00	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	8.66	2.43	1.79	1.69	0.84
glioblastoma cell line:A172, tech_rep2	10444-106F3	8.01	2.25	2.95	2.39	0.56
glioblastoma cell line:T98G	10485-107A8	7.62	1.10	1.43	0.99	0.33
glioma cell line:GI-1	10413-106B8	19.33	3.81	4.39	2.93	0.29
globus pallidus - adult, donor10196	10175-103C4	10.20	0.73	2.92	1.46	2.19
globus pallidus, adult, donor10252	10161-103A8	21.24	3.66	4.39	4.15	0.00
globus pallidus, adult, donor10258	10367-105F7	4.11	9.58	0.00	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	10.13	3.73	3.73	0.53	1.60
granulocyte macrophage progenitor, donor1	12131-128D7	70.97	7.34	9.79	7.34	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	10.45	5.23	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	7.04	0.64	1.28	0.32	0.32
hIPS +CCl2, biol_rep1	14383-156B9	5.51	1.38	1.38	2.30	0.00
hIPS +CCl2, biol_rep2	14384-156C1	7.32	0.46	1.37	1.37	0.00
hIPS +CCl2, biol_rep3	14385-156C2	6.44	1.29	3.22	0.00	0.00
hIPS, biol_rep1	14380-156B6	2.87	0.00	1.44	1.44	0.00
hIPS, biol_rep2	14381-156B7	2.06	0.69	2.74	1.37	0.00
hIPS, biol_rep3	14382-156B8	4.41	5.52	1.10	2.21	0.00
hairy cell leukemia cell line:Mo	10712-109I1	14.37	6.03	2.59	2.30	0.57
heart - mitral valve, adult	10205-103F7	11.96	1.79	0.00	0.00	0.30
heart - pulmonic valve, adult	10206-103F8	12.29	1.31	1.57	0.52	0.78
heart - tricuspid valve, adult	10207-103F9	11.66	1.67	0.00	2.50	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	11.84	0.61	0.82	1.43	0.20
heart, adult, diseased, donor1	10051-101G6	11.92	0.43	2.13	2.13	0.43
heart, adult, pool1	10016-101C7	8.74	0.46	1.61	2.30	0.23
heart, fetal, pool1	10046-101G1	12.94	1.33	2.26	2.26	0.31
hepatic mesenchymal tumor cell line:LI90	10778-110G4	3.70	0.62	0.00	0.62	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	9.51	0.00	2.38	1.19	2.38
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	11.49	1.44	3.76	1.66	0.77
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	12.02	1.46	4.49	1.34	0.61
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	11.72	1.72	3.54	2.22	0.30
hepatoma cell line:Li-7	10484-107A7	17.57	1.33	2.67	4.00	0.78
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	8.44	1.01	2.81	1.81	0.40
hippocampus - adult, donor10196	10169-103B7	7.57	0.95	0.95	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	13.06	1.43	3.27	2.45	0.61
hippocampus, adult, donor10258	10374-105G5	5.98	7.97	3.98	1.49	0.00
hippocampus, newborn, donor10223	10363-105F3	8.46	7.40	2.82	2.82	0.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	12.21	1.83	2.44	3.05	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	16.49	1.37	3.14	1.96	0.59
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	12.19	2.54	1.02	2.29	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	15.79	3.38	1.69	1.69	2.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	18.07	1.55	1.55	2.07	1.03
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	20.50	2.28	1.90	3.04	1.14
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	15.77	1.17	1.75	2.34	0.58
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	13.14	2.15	3.66	1.72	0.65
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	18.35	4.59	0.83	2.09	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	12.55	2.84	3.08	2.37	1.66
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	15.59	1.93	1.93	1.61	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	10.77	2.02	2.02	0.67	1.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	11.11	0.94	1.41	1.10	0.78
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	8.84	1.97	0.98	0.49	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	8.73	0.87	0.87	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	16.80	1.72	0.76	2.48	2.29
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	14.39	1.74	1.74	0.44	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	18.49	2.50	2.50	1.00	2.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	14.69	2.45	0.94	2.45	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	10.00	5.00	0.91	1.36	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	10.96	1.88	0.94	2.51	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	11.10	2.45	1.14	0.98	1.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	11.03	2.61	0.58	2.03	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	11.36	1.79	0.60	2.99	1.49
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	15.70	1.29	1.66	2.77	0.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	12.55	2.00	2.00	1.43	0.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	16.33	2.04	1.63	2.04	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	14.79	2.11	3.17	1.76	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	10.45	2.22	1.90	1.58	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	15.43	3.03	2.12	2.12	0.91
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	11.89	1.55	1.03	0.52	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	11.29	1.99	1.99	1.99	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	9.75	1.54	1.54	1.54	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	11.50	1.53	2.56	1.02	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	7.57	3.79	3.03	0.76	3.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	9.41	3.70	2.02	0.67	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	13.04	0.72	1.93	1.93	0.97
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	13.37	1.78	1.34	1.78	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	15.61	0.49	3.41	0.49	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	18.03	3.67	2.14	3.06	1.83
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	13.01	3.25	6.51	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	10.26	4.63	1.65	1.99	1.32
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	12.59	4.38	1.64	0.55	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	14.11	3.26	1.09	0.72	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	10.32	2.49	1.78	0.71	1.42
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	8.35	2.39	0.00	2.39	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	11.78	2.71	1.76	2.44	1.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	9.16	0.81	0.54	1.62	1.35
immature langerhans cells, donor1	11904-125F5	6.78	0.24	0.48	0.24	0.00
immature langerhans cells, donor2	11905-125F6	12.67	0.00	1.58	2.38	0.00
insula, adult, pool1	10039-101F3	10.88	9.56	7.67	3.12	0.47
keratoacanthoma cell line:HKA-1	10791-110H8	10.73	2.60	2.60	5.20	0.65
kidney, adult, pool1	10017-101C8	11.11	1.10	2.60	1.20	0.50
kidney, fetal, pool1	10045-101F9	14.71	4.67	3.82	2.83	0.50
large cell lung carcinoma cell line:IA-LM	10509-107D5	4.97	2.56	1.85	1.56	0.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	11.75	0.97	0.69	1.38	0.28
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	9.17	1.28	2.57	0.92	0.00
left atrium, adult, donor1	10079-102A7	7.08	1.09	0.54	1.09	0.00
left ventricle, adult, donor1	10078-102A6	6.07	0.00	0.51	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	6.02	2.74	2.74	0.82	0.55
leiomyoma cell line:10964C	10569-108B2	2.16	1.08	2.51	0.72	0.00
leiomyoma cell line:15242A	10570-108B3	2.72	2.72	0.00	0.54	0.54
leiomyoma cell line:15425	10571-108B4	7.53	2.43	1.21	0.97	0.49
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	6.35	0.00	6.35	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	8.36	1.05	1.05	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	12.04	2.95	3.07	1.18	0.12
liposarcoma cell line:KMLS-1	10782-110G8	6.87	1.87	1.09	0.78	0.16
liposarcoma cell line:SW 872	10726-110A6	12.91	1.34	3.29	1.83	0.12
liver, adult, pool1	10018-101C9	9.08	2.27	0.97	1.46	0.65
liver, fetal, pool1	10086-102B5	5.64	0.94	0.00	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	8.60	1.46	1.60	0.73	0.44
locus coeruleus, adult, donor10252	10165-103B3	12.18	1.85	2.40	2.03	0.37
locus coeruleus, adult, donor10258	10375-105G6	10.44	1.97	4.23	2.26	0.00
locus coeruleus, newborn, donor10223	10362-105F2	7.99	1.26	1.68	0.42	0.00
lung adenocarcinoma cell line:A549	10499-107C4	5.67	0.28	1.94	0.69	0.42
lung adenocarcinoma cell line:PC-14	10408-106B3	9.65	1.38	2.07	0.69	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	6.20	1.05	0.66	0.92	0.53
lung, adult, pool1	10019-101D1	12.76	0.35	1.18	2.13	0.12
lung, fetal, donor1	10068-101I5	6.28	5.14	2.57	1.71	0.29
lung, right lower lobe, adult, donor1	10075-102A3	16.04	1.37	0.46	1.83	0.46
lymph node, adult, donor1	10077-102A5	17.51	0.47	0.00	1.42	0.00
lymphangiectasia cell line:DS-1	10727-110A7	9.64	2.41	2.41	2.19	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	8.75	2.57	2.11	1.96	0.45
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	18.69	5.10	6.80	5.10	0.85
mature adipocyte, donor1	12231-129F8	9.77	0.89	1.33	2.66	0.00
mature adipocyte, donor2	12232-129F9	11.62	0.83	2.49	2.49	0.00
mature adipocyte, donor3	12233-129G1	9.48	0.95	2.13	1.90	0.00
mature adipocyte, donor4	12234-129G2	12.37	0.26	2.37	1.05	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	15.01	3.10	3.57	1.43	0.48
medial frontal gyrus - adult, donor10196	10170-103B8	13.54	4.51	2.26	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	12.87	4.60	2.76	2.57	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	10.80	6.04	4.45	1.27	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	5.97	7.68	1.28	0.00	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	15.36	4.39	3.38	2.19	0.17
medial temporal gyrus, adult, donor10252	10156-103A3	12.52	4.03	3.61	1.70	0.42
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	3.85	1.93	3.85	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	9.69	11.84	3.23	0.00	0.00
medulla oblongata - adult, donor10196	10174-103C3	9.73	0.00	1.30	0.65	0.00
medulla oblongata, adult, donor10252	10155-103A2	15.17	2.17	3.87	2.48	0.00
medulla oblongata, adult, pool1	10038-101F2	10.61	3.27	3.43	2.20	0.57
medulla oblongata, newborn, donor10223	10361-105F1	11.80	1.39	1.74	0.35	0.35
medulloblastoma cell line:D283 Med	10838-111E1	11.07	0.44	0.44	0.89	0.00
medulloblastoma cell line:ONS-76	10759-110E3	8.68	1.35	1.22	1.59	0.49
melanoma cell line:COLO 679	10514-107E1	11.36	1.58	4.02	2.44	0.29
melanoma cell line:G-361	10465-106H6	12.76	3.53	1.63	2.44	0.00
meningioma cell line:HKBMM	10691-109F7	9.77	3.26	1.45	1.09	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	14.10	0.00	2.64	2.64	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	19.96	5.18	2.85	3.37	2.07
mesenchymal precursor cell - adipose, donor1	11747-123G1	6.90	1.84	1.53	1.07	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	5.27	2.18	3.27	0.36	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	3.73	0.83	2.48	0.41	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	5.90	1.12	3.23	1.40	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	5.58	1.16	0.77	1.35	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	6.25	0.69	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	6.18	1.54	1.72	1.89	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	5.41	0.81	0.92	1.50	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	6.10	1.72	1.86	1.19	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	5.94	1.62	1.35	1.35	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	5.41	1.99	2.13	0.43	0.57
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	4.28	2.31	0.66	0.33	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	6.92	2.08	0.83	0.83	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	5.24	2.79	0.70	0.35	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	5.51	1.02	1.02	0.61	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	7.19	0.72	1.44	1.08	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	5.17	1.34	0.93	0.83	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	3.19	1.82	0.46	1.14	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	6.71	1.68	0.42	0.42	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	6.43	1.05	0.75	1.20	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	6.21	1.14	1.31	0.88	0.61
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	4.79	0.74	1.47	1.84	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	7.44	2.00	0.00	1.43	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	9.68	2.95	0.42	1.26	0.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	5.94	1.37	1.37	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	5.12	1.28	1.28	0.26	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	6.54	2.09	1.57	1.31	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	7.09	2.16	0.62	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	3.06	1.65	1.18	0.71	0.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	5.42	1.02	2.03	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	6.68	0.79	1.18	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	5.56	1.39	0.93	1.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	6.35	2.31	1.73	0.58	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	5.58	0.89	1.56	0.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	4.33	1.68	0.96	0.96	0.96
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	3.67	0.73	1.47	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	5.37	2.69	0.00	0.67	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	4.50	1.23	0.82	1.23	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	6.01	2.15	0.86	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	5.47	5.47	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	5.16	5.16	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	4.55	1.95	0.32	0.00	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	7.27	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	5.33	2.13	0.53	0.00	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	4.09	0.82	1.64	0.00	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	3.11	1.17	0.39	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	4.20	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	3.97	0.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	0.59	1.78	2.37	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	4.87	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	3.17	1.90	2.53	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	4.48	2.07	2.07	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	6.45	6.45	4.30	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	11.98	7.98	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	3.44	6.89	3.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	6.11	2.04	2.44	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	5.56	3.18	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	2.36	2.36	4.13	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	5.61	4.36	2.18	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	5.35	4.01	1.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	9.46	2.37	3.55	1.18	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	2.57	2.57	5.14	2.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	10.33	3.44	2.07	0.69	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	9.40	2.47	1.98	0.49	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	16.82	3.36	1.12	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	10.18	0.00	2.54	1.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	6.85	2.82	2.82	2.01	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	10.90	0.00	2.18	2.18	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	12.67	0.00	1.27	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	5.46	1.21	2.43	1.82	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	9.04	4.52	4.52	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	11.53	0.82	4.12	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	6.75	1.19	1.59	1.39	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	7.14	3.89	0.97	0.65	0.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	4.07	3.06	1.02	3.06	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	5.42	0.00	0.77	1.55	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	13.23	0.71	1.42	2.36	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	9.04	2.32	1.39	0.93	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	21.37	0.00	0.00	4.27	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	4.62	0.41	1.13	0.82	0.00
mesothelioma cell line:Mero-25	10850-111F4	10.21	1.59	3.18	1.36	0.23
mesothelioma cell line:Mero-41	10851-111F5	17.36	2.20	0.24	1.71	0.73
mesothelioma cell line:Mero-48a	10852-111F6	6.42	1.77	2.44	1.33	0.22
mesothelioma cell line:Mero-82	10853-111F7	15.77	2.37	3.15	1.84	0.53
mesothelioma cell line:Mero-83	10854-111F8	6.64	2.04	1.02	0.51	0.17
mesothelioma cell line:Mero-84	10855-111F9	7.33	3.03	1.52	1.01	1.01
mesothelioma cell line:Mero-95	10856-111G1	15.94	3.52	3.31	1.45	1.04
mesothelioma cell line:NCI-H2052	10847-111F1	7.12	0.99	1.66	1.49	0.33
mesothelioma cell line:NCI-H226	10846-111E9	15.38	4.71	3.08	1.99	0.72
mesothelioma cell line:NCI-H2452	10848-111F2	7.52	1.54	0.85	0.85	0.17
mesothelioma cell line:NCI-H28	10845-111E8	5.85	1.53	0.76	1.02	0.76
mesothelioma cell line:No36	10857-111G2	12.07	3.26	0.98	1.96	0.00
mesothelioma cell line:ONE58	10858-111G3	14.36	2.44	3.52	0.81	1.35
migratory langerhans cells, donor1	11901-125F2	6.14	0.38	0.00	0.00	0.38
migratory langerhans cells, donor2	11902-125F3	6.96	0.49	0.12	1.22	0.37
migratory langerhans cells, donor3	11903-125F4	8.26	1.08	0.18	0.54	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	20.89	1.96	2.61	4.24	1.31
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	5.30	0.21	0.21	0.00	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	3.23	0.00	0.92	0.46	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	9.70	3.04	1.14	1.71	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	11.46	1.48	2.59	1.66	0.37
myeloma cell line:PCM6	10474-106I6	8.10	2.37	2.97	3.16	0.59
myxofibrosarcoma cell line:MFH-ino	10600-108E6	3.55	0.00	1.52	0.51	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	16.67	7.45	7.85	3.92	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	5.13	1.00	1.11	2.01	0.67
nasal epithelial cells, donor1, tech_rep2	12226-129F3	7.06	1.54	0.96	1.76	0.59
nasal epithelial cells, donor2	12227-129F4	3.31	2.76	0.55	1.10	0.00
neuroblastoma cell line:CHP-134	10508-107D4	26.92	2.53	8.74	4.14	1.38
neuroblastoma cell line:NB-1	10539-107G8	16.46	7.86	4.86	3.93	1.12
neuroblastoma cell line:NBsusSR	10607-108F4	20.25	3.37	3.59	4.85	0.21
neuroblastoma cell line:NH-12	10555-107I6	20.68	1.49	3.91	4.29	0.93
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	10.20	2.85	2.85	1.42	1.66
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	18.21	2.69	2.22	2.69	0.32
neuroectodermal tumor cell line:TASK1	10774-110F9	13.08	1.01	2.42	3.42	2.01
neuroepithelioma cell line:SK-N-MC	10728-110A8	10.81	2.54	0.00	2.54	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	1.86	0.53	1.33	1.06	0.27
neutrophil PMN, donor1	12133-128D9	104.12	0.00	0.00	44.62	0.00
neutrophil PMN, donor2	12137-128E4	26.56	0.00	0.00	13.28	0.00
neutrophil PMN, donor3	12141-128E8	28.41	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	24.02	1.86	1.52	1.69	0.34
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	15.21	0.80	4.00	1.60	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	6.73	1.60	1.92	0.96	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	9.20	0.79	3.15	0.53	0.00
nucleus accumbens, adult, pool1	10037-101F1	9.19	7.12	5.16	2.53	0.28
occipital cortex - adult, donor10196	10172-103C1	8.24	6.18	2.06	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	13.95	2.95	2.15	1.61	0.00
occipital cortex, newborn, donor10223	10355-105E4	10.19	6.91	2.18	2.18	0.36
occipital lobe, adult, donor1	10076-102A4	13.12	4.20	3.94	1.57	0.26
occipital lobe, fetal, donor1	10073-102A1	20.17	6.87	3.86	5.15	5.58
occipital pole, adult, pool1	10036-101E9	12.06	4.73	6.86	2.05	0.55
olfactory region, adult	10195-103E6	11.46	5.16	4.97	1.91	0.00
optic nerve, donor1	10277-104E7	16.01	0.00	0.00	2.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	3.87	0.68	1.48	0.23	0.34
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	4.81	1.79	2.34	1.37	0.41
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	6.60	0.85	1.35	0.17	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	6.93	0.92	1.85	2.31	0.35
osteoclastoma cell line:Hs 706.T	10704-109H2	5.29	0.59	2.35	0.88	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	14.02	0.93	2.80	2.80	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	7.21	0.64	2.97	1.48	0.42
ovary, adult, pool1	10020-101D2	12.75	1.40	1.48	1.83	0.35
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	6.60	1.28	1.28	1.65	0.18
pancreas, adult, donor1	10049-101G4	15.99	2.82	1.88	3.76	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	6.43	0.84	1.40	0.56	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	11.41	1.87	2.38	2.21	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	13.25	0.66	2.32	1.82	0.66
paracentral gyrus, adult, pool1	10035-101E8	8.24	6.41	5.49	2.47	0.46
parietal cortex, adult, donor10258	10373-105G4	7.34	3.67	0.00	0.73	0.73
parietal lobe - adult, donor10196	10171-103B9	13.17	2.82	3.76	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	8.84	1.71	1.71	1.14	0.29
parietal lobe, adult, pool1	10034-101E7	9.25	4.85	3.52	2.47	0.18
parietal lobe, fetal, donor1	10072-101I9	15.52	6.79	2.91	1.94	1.94
parietal lobe, newborn, donor10223	10356-105E5	7.85	5.23	1.87	0.37	0.37
parotid gland, adult	10199-103F1	14.80	0.00	1.85	2.47	0.00
penis, adult	10200-103F2	18.80	1.07	2.15	1.07	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	18.41	0.93	0.37	1.67	0.37
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	9.76	1.60	0.87	1.75	0.73
pineal gland - adult, donor10196	10179-103C8	5.16	0.65	0.65	1.29	0.00
pineal gland, adult, donor10252	10160-103A7	10.07	2.37	6.51	1.78	0.59
pineal gland, adult, donor10258	10377-105G8	9.41	2.51	1.25	1.88	0.63
pituitary gland - adult, donor10196	10180-103C9	16.19	4.05	2.02	3.04	1.01
pituitary gland, adult, donor10252	10162-103A9	15.64	3.65	5.21	1.56	0.00
pituitary gland, adult, donor10258	10378-105G9	12.77	3.40	5.96	2.55	0.85
placenta, adult, pool1	10021-101D3	10.97	0.97	1.08	1.51	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	10.59	0.79	1.46	1.32	0.13
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	6.54	1.09	2.18	2.02	0.31
pons, adult, pool1	10033-101E6	8.69	3.27	4.99	1.89	0.26
postcentral gyrus, adult, pool1	10032-101E5	15.17	7.41	5.06	4.10	0.26
promyelocytes/myelocytes PMC, donor1	12132-128D8	39.74	4.18	6.27	6.27	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	33.05	5.51	0.00	5.51	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	5.68	0.87	1.31	0.58	0.15
prostate cancer cell line:PC-3	10439-106E7	9.80	1.09	2.18	2.54	1.27
prostate, adult, pool1	10022-101D4	15.33	2.00	2.09	1.36	0.18
putamen, adult, donor10196	10176-103C5	13.46	5.43	2.12	3.30	0.00
putamen, adult, donor10252	10152-102I8	19.61	1.96	1.96	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	4.37	4.37	1.09	2.19	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	10.39	5.80	3.62	1.93	0.24
putamen, newborn, donor10223	10365-105F5	5.25	2.25	3.75	0.00	0.75
rectal cancer cell line:TT1TKB	10469-106I1	9.31	0.58	1.75	1.75	0.58
rectum, fetal, donor1	10067-101I4	22.26	2.78	0.00	1.39	2.78
renal cell carcinoma cell line:OS-RC-2	10411-106B6	8.48	1.91	1.27	1.27	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	8.28	2.49	0.83	0.41	0.00
retina, adult, pool1	10030-101E3	17.00	2.48	2.29	1.29	0.60
retinoblastoma cell line:Y79	10475-106I7	11.95	4.68	2.08	2.08	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	6.27	1.23	2.70	1.72	0.61
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	15.75	2.53	3.37	3.66	0.84
sacrococcigeal teratoma cell line:HTST	10695-109G2	4.55	0.76	0.00	1.52	0.00
salivary acinar cells, donor1	11771-123I7	4.86	3.72	2.10	0.49	0.00
salivary acinar cells, donor2	11772-123I8	7.57	2.34	2.20	1.24	0.00
salivary acinar cells, donor3	11773-123I9	3.97	1.32	1.99	1.32	0.00
salivary gland, adult, pool1	10093-102C3	8.01	1.14	1.72	0.57	1.14
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	10.62	3.29	2.78	2.19	0.08
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	10.70	2.47	2.35	2.23	0.12
seminal vesicle, adult	10201-103F3	10.05	3.17	1.59	4.23	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	5.34	0.97	1.21	0.73	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	7.30	1.26	1.76	0.75	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	12.04	3.01	2.01	1.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	8.87	0.27	2.69	2.01	0.54
signet ring carcinoma cell line:Kato III	10436-106E4	8.07	0.77	1.55	0.88	0.88
signet ring carcinoma cell line:NUGC-4	10483-107A6	11.87	1.81	4.13	1.55	0.52
skeletal muscle - soleus muscle, donor1	10282-104F3	5.67	0.00	0.71	1.42	0.00
skeletal muscle, adult, pool1	10023-101D5	8.76	0.36	1.08	1.20	0.12
skeletal muscle, fetal, donor1	10066-101I3	10.05	1.01	2.01	2.01	1.01
skin, adult, donor1	10074-102A2	6.79	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	12.62	2.52	1.26	0.63	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	10.01	1.00	2.67	1.33	1.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	30.26	2.21	4.73	4.10	0.95
small cell lung carcinoma cell line:DMS 144	10841-111E4	26.41	7.32	6.17	2.31	0.77
small cell lung carcinoma cell line:LK-2	10541-107H1	8.74	3.79	1.48	1.48	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	17.05	0.32	2.41	2.73	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	22.66	1.31	6.76	5.01	0.00
small intestine, adult, pool1	10024-101D6	12.18	1.67	1.55	2.63	0.48
small intestine, fetal, donor1	10064-101I1	14.25	1.23	0.25	1.23	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	30.77	5.64	3.59	3.08	0.00
smooth muscle, adult, pool1	10048-101G3	13.18	1.03	1.55	2.84	0.52
somatostatinoma cell line:QGP-1	10781-110G7	12.06	2.68	3.75	2.68	0.54
spinal cord - adult, donor10196	10181-103D1	11.70	0.92	2.06	0.69	0.00
spinal cord, adult, donor10252	10159-103A6	9.46	2.76	1.58	1.18	0.00
spinal cord, adult, donor10258	10369-105F9	4.84	2.08	0.69	0.00	0.69
spinal cord, fetal, donor1	10056-101H2	18.90	3.05	4.27	1.83	1.83
spinal cord, newborn, donor10223	10359-105E8	13.32	2.76	0.92	0.92	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	5.23	1.05	0.75	1.49	0.30
spleen, adult, pool1	10025-101D7	13.66	1.21	1.76	1.32	0.55
spleen, fetal, pool1	10044-101F8	17.64	3.10	1.35	2.22	0.79
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	5.28	1.97	0.62	1.35	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	6.27	0.95	0.76	0.76	0.57
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	8.39	0.70	1.40	0.70	1.05
squamous cell carcinoma cell line:T3M-5	10616-108G4	14.46	2.74	1.17	0.78	1.17
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	24.31	1.24	4.61	3.26	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	16.10	1.27	1.27	1.69	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	10.15	1.69	0.00	2.12	0.42
stomach, fetal, donor1	10062-101H8	10.68	2.14	1.07	0.00	0.00
submaxillary gland, adult	10202-103F4	22.22	0.57	2.28	3.42	1.71
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	17.45	1.87	4.57	2.28	0.42
substantia nigra, adult, donor10258	10371-105G2	5.17	4.14	3.10	0.52	0.00
substantia nigra, newborn, donor10223	10358-105E7	11.31	2.83	6.36	2.83	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	15.59	3.90	4.36	1.60	1.38
temporal lobe, adult, pool1	10031-101E4	13.39	8.31	5.34	2.63	0.76
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	23.50	8.55	4.99	2.14	6.41
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	23.30	9.67	4.83	2.64	3.52
tenocyte, donor1	11763-123H8	9.08	1.05	1.05	2.09	0.35
tenocyte, donor2	11765-123I1	9.16	2.29	3.43	2.29	0.76
tenocyte, donor3	11768-123I4	6.67	0.74	1.48	2.59	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	10.03	1.87	2.89	0.68	0.51
teratocarcinoma cell line:NCR-G1	10798-110I6	15.72	2.47	2.93	3.70	1.08
teratocarcinoma cell line:PA-1	10807-111A6	9.61	1.08	0.93	2.01	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	6.86	2.03	1.78	1.02	0.89
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	16.26	1.51	3.78	2.65	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	18.76	6.22	4.80	4.80	0.22
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	29.96	1.95	2.61	3.91	0.65
testis, adult, pool1	10026-101D8	19.00	1.72	2.47	2.47	0.11
testis, adult, pool2	10096-102C6	22.55	4.51	0.90	3.16	0.00
thalamus - adult, donor10196	10168-103B6	11.04	2.21	2.21	3.31	1.10
thalamus, adult, donor10252	10154-103A1	16.10	2.97	2.03	3.13	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	6.16	4.62	3.08	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	8.89	3.46	3.95	1.81	0.33
thalamus, newborn, donor10223	10366-105F6	7.48	5.18	0.58	0.58	0.00
throat, adult	10209-103G2	12.98	1.50	1.75	1.25	0.25
throat, fetal, donor1	10061-101H7	12.80	0.61	0.91	0.91	0.91
thymic carcinoma cell line:Ty-82	10803-111A2	19.08	3.58	5.17	2.58	0.20
thymus, adult, pool1	10027-101D9	30.82	2.09	2.09	2.39	0.80
thymus, fetal, pool1	10043-101F7	26.29	1.77	1.77	2.29	1.04
thyroid carcinoma cell line:KHM-5M	10776-110G2	6.91	0.27	0.53	0.66	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	9.78	1.12	1.26	1.26	0.42
thyroid, adult, pool1	10028-101E1	16.80	1.21	2.15	2.89	0.37
thyroid, fetal, donor1	10060-101H6	22.41	1.85	1.32	2.11	1.05
tongue epidermis (fungiform papillae), donor1	10288-104F9	9.24	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	13.02	0.93	1.40	2.09	0.93
tongue, fetal, donor1	10059-101H5	12.61	0.00	0.00	1.97	0.39
tonsil, adult, pool1	10047-101G2	20.54	1.70	2.40	2.80	0.90
trachea, adult, pool1	10029-101E2	11.21	1.47	0.74	1.80	0.33
trachea, fetal, donor1	10058-101H4	14.62	2.31	0.77	2.31	1.54
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	3.54	0.00	1.42	1.06	0.71
transitional-cell carcinoma cell line:5637	10418-106C4	10.74	2.23	2.43	1.01	2.13
transitional-cell carcinoma cell line:JMSU1	10492-107B6	8.30	0.94	1.10	0.47	0.00
tridermal teratoma cell line:HGRT	10694-109G1	9.51	0.00	1.90	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	6.26	0.59	1.86	0.76	0.42
umbilical cord, fetal, donor1	10057-101H3	14.61	0.00	4.17	0.00	0.00
uterus, adult, pool1	10100-102D1	12.29	5.46	2.22	2.22	0.51
uterus, fetal, donor1	10055-101H1	13.82	3.07	1.02	2.05	0.00
vagina, adult	10204-103F6	13.57	1.29	1.94	2.58	0.00
vein, adult	10191-103E2	16.88	2.19	1.32	1.53	0.66
xeroderma pigentosum b cell line:XPL 17	10563-108A5	7.48	2.67	1.87	0.80	0.00